,Unnamed: 0.1,Unnamed: 0,Date,Open,High,Low,Close,Adj Close,Volume,Volatility,mr,Daily Return,list,combina-Open,combina-High,combina-Low,combina-Close,combina-Adj_Close,combina-Volume,beta,future-MD,future-Volatility,change,z_future-Volatility,z_change,z_beta,z_future-MD,scaled_future-Volatility,scaled_change,scaled_beta,scaled_future-MD,risk,label-risk
0,339,339,2014-01-10,80.629997,81.370003,80.589996,81.339996,71.066635,1641100,0.0042641980497452,2.1499939999999924,0.0065585696462955,['$nvs - [ $$] japan probe could spell more trouble for novartis -> URL stock stocks stockaction'],"[80.629997, 79.800003]","[81.370003, 81.040001]","[80.589996, 79.269997]","[81.339996, 80.809998]","[71.066635, 70.603577]","[1641100, 2696100]",0.667922624284153,0.0172907080145628,0.0083100894786193,0.0050416073747528,-0.0163863198917009,0.32006879701618,-0.0219511292300469,-0.3439329481644297,0.26595272091161,0.1137986237609086,0.4899933242982544,0.1795403444526636,0.2623212533558592,1.0
1,340,340,2014-01-13,80.940002,81.199997,80.330002,80.389999,70.236633,1175300,0.0092812787828431,1.869995000000003,-0.0116793342355216,"['rt AT_USER novartis oncology chief hoppenot leaps to ceo job at partner incyte URL $nvs $incy pharma by AT_USER', 'the next home run in healthcare URL $gern $mnkd $nvs $ocrx $incy $icpt', '$nvs - [ $$] japan probe could spell more trouble for novartis -> URL stock stocks stockaction']","[80.940002, 80.629997]","[81.199997, 81.370003]","[80.330002, 80.589996]","[80.389999, 81.339996]","[70.236633, 71.066635]","[1175300, 1641100]",0.3020140197153573,0.0128808648224143,0.0060847168912563,0.0038748597432196,-0.5516135489467049,0.0252863732722393,-0.4007502862726092,-0.6869016899266613,0.1859009249704106,0.0874469739778501,0.4542982456737136,0.1288759562134233,0.2141305252088494,1.0
2,341,341,2014-01-14,80.529999,80.940002,80.389999,80.739998,70.542419,917400,0.0093040241474086,1.629997000000003,0.0043537629599921,"['rt AT_USER novartis oncology chief hoppenot leaps to ceo job at partner incyte URL $nvs $incy pharma by AT_USER', 'the next home run in healthcare URL $gern $mnkd $nvs $ocrx $incy $icpt']","[80.529999, 80.940002]","[80.940002, 81.199997]","[80.389999, 80.330002]","[80.739998, 80.389999]","[70.542419, 70.236633]","[917400, 1175300]",0.4285702772794602,0.0122539669234562,0.0070249051290188,0.0030020863174506,-0.325487664164407,-0.1952225516007462,-0.2697355927530686,-0.7356577055604722,0.2197216691384085,0.0677348965463301,0.4666440487178969,0.1216735689276969,0.2189435458325831,1.0
3,342,342,2014-01-15,80.760002,81.089996,80.510002,80.839996,70.629799,1533000,0.0070908793775184,0.9499969999999962,0.0012385187326855,['rt AT_USER the next home run in healthcare URL $gern $mnkd $nvs $ocrx $incy $icpt'],"[80.760002, 80.529999]","[81.089996, 80.940002]","[80.510002, 80.389999]","[80.839996, 80.739998]","[70.629799, 70.542419]","[1533000, 917400]",-0.8553256108920114,0.0123777693727222,0.0086057860906382,0.0019032683650148,0.0547320533598397,-0.4728423303070741,-1.5988617026539005,-0.7260291613239239,0.2765896115519726,0.0429174766730405,0.341397568854402,0.1230959268395948,0.1960001459797525,0.0
4,343,343,2014-01-16,81.68,81.879997,81.510002,81.779999,71.45108,1404700,0.0084380045549665,1.3900000000000006,0.0116279446624416,['rt AT_USER the next home run in healthcare URL $gern $mnkd $nvs $ocrx $incy $icpt'],"[81.68, 80.760002]","[81.879997, 81.089996]","[81.510002, 80.510002]","[81.779999, 80.839996]","[71.45108, 70.629799]","[1404700, 1533000]",0.7782113285364086,0.0244239115442842,0.012003882738085,0.0017262072119129,0.8720126575166555,-0.5175773822168751,0.0922229231984363,0.2108409366934866,0.3988270026992345,0.0389184512020443,0.500752196651973,0.2614932342204398,0.2999977211934229,1.0
5,348,348,2014-01-24,80.410004,80.5,79.650002,79.839996,69.756096,2208400,0.013425630445398,1.9500050000000044,-0.0238416062618705,"['$nvs - europe markets : spanish stocks sink as banks battered by argentina woes URL', 'rt AT_USER $nvs - mixed chmp day negative on serelaxin in ahf URL positive on xolair in severe form of csu URL']","[80.410004, 81.830002]","[80.5, 82.019997]","[79.650002, 81.449997]","[79.839996, 81.790001]","[69.756096, 71.459808]","[2208400, 2870100]",0.9681292223073704,0.0147245876456536,0.0095874754500803,9.052132311285384e-05,0.2908394264040953,-0.9308385174896568,0.2888314127760937,-0.5435089956080652,0.311903246997095,0.0019755678125071,0.5192790475259788,0.1500583622201624,0.2458040561389358,1.0
6,349,349,2014-01-27,79.459999,79.470001,78.639999,78.779999,68.829979,2397800,0.0132460124595969,3.010002,-0.0132765161962181,"['$nvs - europe markets : spanish stocks sink as banks battered by argentina woes URL', 'rt AT_USER $nvs - mixed chmp day negative on serelaxin in ahf URL positive on xolair in severe form of csu URL']","[79.459999, 80.410004]","[79.470001, 80.5]","[78.639999, 79.650002]","[78.779999, 79.839996]","[68.829979, 69.756096]","[2397800, 2208400]",0.5247059826424768,0.0167896076015159,0.0081595515526824,0.0011818788028628,-0.052592390472614,-0.6551036504481775,-0.1702131335965878,-0.3829052586686265,0.2605375237455516,0.0266244887249929,0.4760222691770809,0.1737832359190419,0.2342418793916668,1.0
7,350,350,2014-01-28,79.379997,79.629997,79.07,79.559998,69.511459,2051200,0.0154148544761718,3.010002,0.0099009775311116,"['$nvs the zacks analyst blog highlights : hanesbrands , teva pharmaceutical , n ... URL']","[79.379997, 79.459999]","[79.629997, 79.470001]","[79.07, 78.639999]","[79.559998, 78.779999]","[69.511459, 68.829979]","[2051200, 2397800]",0.2884819758267646,0.0222507041784159,0.0064117333800357,0.0007034726438704,-0.4729623917703247,-0.7759744568422643,-0.4147590489911096,0.0418230910731914,0.1976644639740956,0.0158194172467165,0.4529781691176477,0.2365254027327435,0.2257468632678008,1.0
8,351,351,2014-01-29,79.129997,79.620003,78.839996,79.269997,69.258087,4029200,0.0125146484155351,3.010002,-0.0036450604234553,"['$nvs - [ $$] novartis earnings miss forecasts -> URL stock stocks stockaction', '$nvs novartis keeps ceo pay steady , but incoming chairman pay drops URL', '$nvs the zacks analyst blog highlights : hanesbrands , teva pharmaceutical , n ... URL']","[79.129997, 79.379997]","[79.620003, 79.629997]","[78.839996, 79.07]","[79.269997, 79.559998]","[69.258087, 69.511459]","[4029200, 2051200]",0.3094397908823387,0.0222507041784159,0.0071370199567694,0.0046148458818789,-0.29852278244811,0.2122461763997258,-0.3930629134605969,0.0418230910731914,0.2237546986472822,0.104159976038667,0.4550226437401805,0.2365254027327435,0.2548656802897183,1.0
9,352,352,2014-01-30,79.690002,80.0,79.660004,79.940002,69.84346,2659600,0.009480058530415,1.1600030000000032,0.008452189041965,"['$nvs - [ $$] novartis earnings miss forecasts -> URL stock stocks stockaction', '$nvs novartis keeps ceo pay steady , but incoming chairman pay drops URL']","[79.690002, 79.129997]","[80.0, 79.620003]","[79.660004, 78.839996]","[79.940002, 79.269997]","[69.84346, 69.258087]","[2659600, 4029200]",0.3132345185055286,0.0130435299121558,0.0071592795728793,0.000692259749433,-0.2931690934892434,-0.7788074295521367,-0.3891345018110146,-0.6742506638637364,0.2245554284921082,0.0155661677356115,0.4553928266196679,0.1307448043562115,0.2065648068008998,1.0
10,356,356,2014-02-05,78.529999,78.75,78.370003,78.550003,68.629028,1732700,0.0055685373828368,1.740005000000011,0.0044757802228561,"['rt AT_USER novartis vaccine unit is no wallflower . it has suitors flirting with a deal , too - URL $nvs $mrk by AT_USER']","[78.529999, 78.43]","[78.75, 78.489998]","[78.370003, 77.900002]","[78.550003, 78.199997]","[68.629028, 68.323227]","[1732700, 2981200]",0.5985570124501304,0.0334511735237165,0.0085637277100144,0.00133119805146,0.0446165380310146,-0.6173776771327099,-0.0937604142875378,0.912922291458282,0.2750766743825149,0.0299969477200305,0.4832265772544873,0.3652068325809435,0.2883767579844941,1.0
11,357,357,2014-02-06,79.550003,79.610001,79.089996,79.220001,69.214401,1920300,0.0061735313719628,1.020004,0.0085295731942873,"['rt AT_USER novartis vaccine unit is no wallflower . it has suitors flirting with a deal , too - URL $nvs $mrk by AT_USER']","[79.550003, 78.529999]","[79.610001, 78.75]","[79.089996, 78.370003]","[79.220001, 78.550003]","[69.214401, 68.629028]","[1920300, 1732700]",0.7275679934386592,0.0208436853807366,0.0086642406982698,0.0014460756933695,0.0687910463778277,-0.5883534830389356,0.0397954798278208,-0.0676056222958139,0.2786923589069639,0.0325915237068913,0.4958118432261402,0.2203602595475043,0.2568639963468749,1.0
12,364,364,2014-02-18,82.599998,82.940002,82.589996,82.720001,72.272354,1968700,0.0054915912595953,2.08000100000001,-0.0026525318868452,['rt AT_USER fda launches secure supply chain pilot ; prequalified $abbv $agn astellas $bms $celg ge health $gsk $mrk myl $nvs $pfe $…'],"[82.599998, 82.559998]","[82.940002, 82.940002]","[82.589996, 82.489998]","[82.720001, 82.940002]","[72.272354, 72.464554]","[1968700, 1937600]",1.314114302624558,0.0249510879415096,0.0075222073412197,0.0059093726181956,-0.2058808681830588,0.5393123890230265,0.6470051620048114,0.2518412665839135,0.2376107792309288,0.1333975885850892,0.5530305485583031,0.2675499279611936,0.2978972110838787,1.0
13,365,365,2014-02-19,82.220001,82.550003,81.690002,81.760002,71.433594,3414500,0.0076100733432784,1.1800000000000068,-0.0116054036314626,"[""novartis , teva say they're experiencing shortages of an adhd medication $nvs $teva"", 'rt AT_USER fda launches secure supply chain pilot ; prequalified $abbv $agn astellas $bms $celg ge health $gsk $mrk myl $nvs $pfe $…']","[82.220001, 82.599998]","[82.550003, 82.940002]","[81.690002, 82.589996]","[81.760002, 82.720001]","[71.433594, 72.272354]","[3414500, 1968700]",0.8461702883197397,0.0184735539435288,0.0049742729357311,0.0010739400724616,-0.8186878558343015,-0.6823747069333727,0.1625760014206655,-0.2519389333481346,0.1459556890864829,0.0241866319471543,0.5073817221193139,0.1931299808095838,0.2176635059906337,1.0
14,366,366,2014-02-20,81.860001,82.580002,81.690002,82.279999,71.887909,3033300,0.0078636060091839,1.1800000000000068,0.0063600414295488,"[""novartis , teva say they're experiencing shortages of an adhd medication $nvs $teva""]","[81.860001, 82.220001]","[82.580002, 82.550003]","[81.690002, 81.690002]","[82.279999, 81.760002]","[71.887909, 71.433594]","[3033300, 3414500]",-0.0806417898588125,0.0151423374266867,0.0073198671059995,0.0021452421026753,-0.2545459789327042,-0.411706911693702,-0.7968866336945302,-0.5110191517452576,0.2303321332583298,0.0483825892811099,0.416969445425948,0.1548578610165826,0.2126355072454926,1.0
15,370,370,2014-02-26,83.809998,83.940002,83.330002,83.410004,72.875206,1471000,0.0053904264528829,1.520004,-0.0046539258477115,['novartis confirms closure of horsham r & d facility URL $nvs'],"[83.809998, 83.93]","[83.940002, 84.330002]","[83.330002, 83.620003]","[83.410004, 83.800003]","[72.875206, 73.215942]","[1471000, 2292600]",1.4300318380790262,0.0232500796746207,0.0139131270279976,0.0024230556469142,1.3312074623245578,-0.3415164543005968,0.7670063430875818,0.1195479764141538,0.4675069330470296,0.054657164026253,0.5643385240755399,0.2480071597772236,0.3336274452315115,1.0
16,371,371,2014-02-27,82.269997,82.620003,82.18,82.550003,74.554138,2166300,0.0079002578208071,1.25,-0.010310525821339,['novartis confirms closure of horsham r & d facility URL $nvs'],"[82.269997, 83.809998]","[82.620003, 83.940002]","[82.18, 83.330002]","[82.550003, 83.410004]","[74.554138, 72.875206]","[2166300, 1471000]",1.5123498029726794,0.0311231266930355,0.0133355834925073,0.0002925446852649,1.1923017222635652,-0.8797966857013868,0.8522242781725503,0.7318620456645522,0.4467313570770688,0.0065383787782607,0.5723687977351436,0.338460061022545,0.3410246486532545,1.0
17,376,376,2014-03-06,84.300003,84.370003,83.730003,83.82,75.701126,2067300,0.0147735083517078,2.529998999999989,0.0086642842037132,"['worst largecaps : $c , $cci , $cig , $nvs , $nmr , $mmc , $chl , $nrg URL']","[84.300003, 83.190002]","[84.370003, 83.389999]","[83.730003, 82.949997]","[83.82, 83.099998]","[75.701126, 75.050865]","[2067300, 1694600]",0.6687874557540217,0.0181238663666977,0.0048477839919001,0.0003180574161907,-0.8491098747345087,-0.8733508147560551,-0.0210558307110188,-0.279135344424424,0.1414055893962662,0.0071145981184128,0.4900776902490095,0.1891124440439787,0.2069275804519168,1.0
18,377,377,2014-03-07,83.699997,83.769997,82.870003,83.139999,75.086983,1940400,0.0086488501919898,2.529998999999989,-0.0081126342161773,"['rt AT_USER $nvs opens p1 trial of abl 001 in cml | ph + all URL the so called pona killer ? $aria URL', 'worst largecaps : $c , $cci , $cig , $nvs , $nmr , $mmc , $chl , $nrg URL']","[83.699997, 84.300003]","[83.769997, 84.370003]","[82.870003, 83.730003]","[83.139999, 83.82]","[75.086983, 75.701126]","[1940400, 2067300]",0.9819041573420556,0.0160559635276854,0.0048434451949497,0.0028291565978206,-0.8501534043809069,-0.2389137839736836,0.3030916234251541,-0.4399632931472575,0.1412495128407823,0.0638291818179582,0.5206228185741903,0.1653544490968381,0.2227639905824422,1.0
19,378,378,2014-03-10,83.129997,83.129997,82.489998,82.900002,74.870239,1641600,0.0068208241967618,1.25,-0.0028866610883649,['rt AT_USER $nvs opens p1 trial of abl 001 in cml | ph + all URL the so called pona killer ? $aria URL'],"[83.129997, 83.699997]","[83.129997, 83.769997]","[82.489998, 82.870003]","[82.900002, 83.139999]","[74.870239, 75.086983]","[1641600, 1940400]",0.869448951065435,0.0148303353268947,0.0064820834508335,0.0004686526717377,-0.4560424055753173,-0.8353024543097202,0.1866747455197253,-0.5352846330629055,0.200195118635672,0.010515876446229,0.5096525998374286,0.1512732901312812,0.2179092212626527,1.0
20,385,385,2014-03-19,82.07,82.300003,80.709999,81.209999,73.343925,1267400,0.0097461318886354,1.4300000000000068,-0.0173039692316551,['says a lot about $nvs options rt AT_USER proteon sets out on its own after $nvs waves off a $550m deal . URL'],"[82.07, 82.489998]","[82.300003, 83.190002]","[80.709999, 82.360001]","[81.209999, 82.639999]","[73.343925, 74.635414]","[1267400, 1416600]",0.845446850405518,0.0093700159120944,0.0061798134683232,0.0028223015092351,-0.5287417486355286,-0.2406457434596932,0.1618270775947206,-0.9599525402230114,0.1893217686643139,0.0636743557966707,0.5073111493781821,0.0885400520800385,0.2122118314798013,1.0
21,386,386,2014-03-20,80.720001,81.459999,80.639999,81.309998,73.434242,1129500,0.0098158898516955,1.4300000000000068,0.0012313631477818,"[""$pfe menb vax rlp 2086 gets fda breakthrough designation . now h2h with $nvs bexsero which's on a real-world s & t trial URL"", 'says a lot about $nvs options rt AT_USER proteon sets out on its own after $nvs waves off a $550m deal . URL']","[80.720001, 82.07]","[81.459999, 82.300003]","[80.639999, 80.709999]","[81.309998, 81.209999]","[73.434242, 73.343925]","[1129500, 1267400]",1.3818543951735451,0.0093700159120944,0.0063218291482589,0.0041812951168361,-0.4945853744238656,0.1027082250199463,0.7171316625438744,-0.9599525402230114,0.1944304009424417,0.0943679887958287,0.5596387231116706,0.0885400520800385,0.2342442912324949,1.0
22,387,387,2014-03-21,82.300003,82.5,81.529999,81.730003,73.81356,1783900,0.0095072268248007,1.4300000000000068,0.0051654779280649,"['$nvs is growing in generic drug business $azn $pfe $mrk URL URL', ""$pfe menb vax rlp 2086 gets fda breakthrough designation . now h2h with $nvs bexsero which's on a real-world s & t trial URL""]","[82.300003, 80.720001]","[82.5, 81.459999]","[81.529999, 80.639999]","[81.730003, 81.309998]","[73.81356, 73.434242]","[1783900, 1129500]",1.1207471593289469,0.0093700159120944,0.006001131229159,0.0025281251702554,-0.5717168442632335,-0.3149703119172273,0.4468259096846206,-0.9599525402230114,0.1828941554955731,0.0570302181530668,0.534167216848808,0.0885400520800385,0.2156579106443716,1.0
23,388,388,2014-03-24,81.769997,81.900002,80.769997,81.300003,73.425217,1102300,0.0085698021487235,1.4300000000000068,-0.0052612257948894,['$nvs is growing in generic drug business $azn $pfe $mrk URL URL'],"[81.769997, 82.300003]","[81.900002, 82.5]","[80.769997, 81.529999]","[81.300003, 81.730003]","[73.425217, 73.81356]","[1102300, 1783900]",2.524229285261079,0.0482060899000606,0.0173375949032774,0.0018752829778196,2.154830644474824,-0.4799129255616563,1.8997511472692965,2.0604631186268305,0.590692958216834,0.0422854110039274,0.6710795611002425,0.5347250624036264,0.4596957481811575,2.0
24,390,390,2014-03-26,81.849998,82.169998,81.110001,81.110001,73.253616,1176600,0.0068674921711327,0.7600020000000001,-0.0092830337382545,['ldk 378 rt AT_USER $nvs alk inhibitor ceritinib lung cancer data in today ’ s nejm — > URL $aria'],"[81.849998, 81.669998]","[82.169998, 82.110001]","[81.110001, 81.209999]","[81.110001, 81.870003]","[73.253616, 73.94001]","[1176600, 1914500]",2.0271322778345247,0.0448567514493025,0.017072862337989,0.0004229889960798,2.091159474009012,-0.8468395242155784,1.3851419660955968,1.799973494814899,0.5811699159111096,0.0094845367149772,0.6225868048694208,0.4962447409454955,0.4273714996102508,2.0
25,391,391,2014-03-27,81.389999,81.660004,81.07,81.370003,73.488434,1086300,0.0064998431783277,0.7600020000000001,0.0032055479816848,['ldk 378 rt AT_USER $nvs alk inhibitor ceritinib lung cancer data in today ’ s nejm — > URL $aria'],"[81.389999, 81.849998]","[81.660004, 82.169998]","[81.07, 81.110001]","[81.370003, 81.110001]","[73.488434, 73.253616]","[1086300, 1176600]",4.0348910655472565,0.0420394799382022,0.019322335959645,0.0037651623888268,2.632183273883326,-0.0024290050428761,3.463631859020179,1.5808645552759644,0.6620886817656398,0.084969397690604,0.818447483988936,0.4638773003372059,0.5073457159455964,2.0
26,392,392,2014-03-28,82.0,82.220001,81.419998,81.589996,73.687119,896400,0.0061269333118478,0.7600020000000001,0.0027036130255519,"['AT_USER looks like $nvs was relatively unharmed by the "" rejection "" it was given yesterday at adcomm . seems adcomms are muted lately .']","[82.0, 81.389999]","[82.220001, 81.660004]","[81.419998, 81.07]","[81.589996, 81.370003]","[73.687119, 73.488434]","[896400, 1086300]",1.5731337556369782,0.0304204937481398,0.0203881583753371,0.0007919439548844,2.888525596717261,-0.7536219045098974,0.9151495817687448,0.677215853831558,0.7004287777185801,0.0178175914368157,0.5782983876446768,0.3303875589496237,0.4067330789374241,2.0
27,393,393,2014-03-31,84.739998,85.230003,84.540001,85.019997,76.784882,2309200,0.0189997018027436,3.909996000000007,0.0420394799382022,"['rt AT_USER $nvs has achieved a milestone in developing a treatment for the most common type of lung cancer URL', 'in case you wanted more : fda advisors think $nvs serelaxin could perform better on more difficult endpoints URL', 'AT_USER looks like $nvs was relatively unharmed by the "" rejection "" it was given yesterday at adcomm . seems adcomms are muted lately .']","[84.739998, 82.0]","[85.230003, 82.220001]","[84.540001, 81.419998]","[85.019997, 81.589996]","[76.784882, 73.687119]","[2309200, 896400]",0.079618534798646,0.0249666458619161,0.0057438378736979,0.0057680878633792,-0.6335988007858,0.5036163555902285,-0.630980516348227,0.2530512598090138,0.1736387187631539,0.1302065931393006,0.4326031441627779,0.2677286718496551,0.2510442819787219,1.0
28,394,394,2014-04-01,84.540001,84.860001,83.989998,84.510002,76.324287,1506400,0.0182205591445796,3.909996000000007,-0.0059985299693671,"[""$nvs novartis ' lead ceritinib could capture market share from pfizer URL"", 'rt AT_USER $nvs has achieved a milestone in developing a treatment for the most common type of lung cancer URL', 'in case you wanted more : fda advisors think $nvs serelaxin could perform better on more difficult endpoints URL']","[84.540001, 84.739998]","[84.860001, 85.230003]","[83.989998, 84.540001]","[84.510002, 85.019997]","[76.324287, 76.784882]","[1506400, 2309200]",0.6312959067133311,0.0249666458619161,0.0088478944257664,0.0030564679568714,0.1129618410716306,-0.1814828609921037,-0.0598681652544206,0.2530512598090138,0.2852988080026723,0.0689631363797913,0.4864203185063024,0.2677286718496551,0.2771027336846053,1.0
29,395,395,2014-04-02,84.129997,84.690002,84.07,84.57,76.378479,1165200,0.0184919183954187,3.649994000000007,0.0007099514682296,"['novartis ag $nvs trading near $85.32 resistance level ( URL )', 'rt AT_USER nice featured article in nature on cancer immunotherapy by AT_USER URL $bmy $mrk $nvs URL', ""$nvs positive news for novartis ' lcz URL"", ""$nvs novartis ' lead ceritinib could capture market share from pfizer URL""]","[84.129997, 84.540001]","[84.690002, 84.860001]","[84.07, 83.989998]","[84.57, 84.510002]","[76.378479, 76.324287]","[1165200, 1506400]",0.6648681187906713,0.0184219726476312,0.0096891437513138,0.0005907966036772,0.315291800564243,-0.8044424094040141,-0.0251132415489859,-0.2559505889516633,0.3155604907998852,0.0132745656696782,0.4896953514919646,0.1925373668123578,0.2527669436934714,1.0
30,396,396,2014-04-03,83.900002,83.910004,83.129997,83.410004,75.330849,1323600,0.0212223711376704,3.4300010000000043,-0.0137164006148751,"['novartis ag $nvs trading near $85.32 resistance level ( URL )', 'rt AT_USER nice featured article in nature on cancer immunotherapy by AT_USER URL $bmy $mrk $nvs URL', ""$nvs positive news for novartis ' lcz URL""]","[83.900002, 84.129997]","[83.910004, 84.690002]","[83.129997, 84.07]","[83.410004, 84.57]","[75.330849, 76.378479]","[1323600, 1165200]",0.5013891229873809,0.0184219726476312,0.0076050283871538,0.0110269125412074,-0.1859614716853814,1.832274792665901,-0.1943514202396106,-0.2559505889516633,0.2405900436949571,0.2489800985961154,0.4737476652779819,0.1925373668123578,0.288963793595353,1.0
31,401,401,2014-04-10,84.459999,84.650002,83.75,83.830002,75.710152,2665200,0.0053260331363611,1.5199970000000036,-0.0023800666711897,['$nvs - [ video ] pfizer ceo worries about aca coverage -> URL stock stocks stockaction'],"[84.459999, 83.089996]","[84.650002, 84.110001]","[83.75, 83.07]","[83.830002, 84.029999]","[75.710152, 75.890785]","[2665200, 1709700]",1.1365003417742183,0.0241925734654063,0.0092956050815651,0.0038226681274412,0.2206413079089065,0.0120999989591824,0.4631340591965422,0.1928489749893358,0.3014039951799654,0.0862681970569173,0.5357039696853075,0.2588354067803037,0.2955528921756235,1.0
32,402,402,2014-04-11,82.900002,83.449997,82.580002,82.669998,74.662514,1834400,0.0096146382638044,1.510002,-0.0138375757166269,"['rt AT_USER appears fda close to approving $nvs alk inhibitor ceritinib ( brand name : zykadia ) this email sent out then retracted . h …', 'rt AT_USER miracle survivors may give doctors crucial clues to cancer cures URL $pfe $nvs', '$nvs - [ video ] pfizer ceo worries about aca coverage -> URL stock stocks stockaction']","[82.900002, 84.459999]","[83.449997, 84.650002]","[82.580002, 83.75]","[82.669998, 83.830002]","[74.662514, 75.710152]","[1834400, 2665200]",0.479043867320606,0.0199307552222131,0.0050154556878137,0.0028374441217073,-0.8087829390544339,-0.2368199152465221,-0.2174838743682848,-0.1386073550429259,0.1474371278732884,0.0640163601940943,0.4715678431913958,0.2098716671029709,0.2232232495904373,1.0
33,403,403,2014-04-14,83.279999,83.989998,83.160004,83.830002,75.710152,2669500,0.0105009023571067,1.360000999999997,0.0140317409950825,"['rt AT_USER breaking : novartis slams the brakes on rnai development efforts $nvs - URL', 'rt AT_USER breaking : novartis slams the brakes on rnai development efforts $nvs - URL', 'rt AT_USER appears fda close to approving $nvs alk inhibitor ceritinib ( brand name : zykadia ) this email sent out then retracted . h …', 'rt AT_USER miracle survivors may give doctors crucial clues to cancer cures URL $pfe $nvs']","[83.279999, 82.900002]","[83.989998, 83.449997]","[83.160004, 82.580002]","[83.830002, 82.669998]","[75.710152, 74.662514]","[2669500, 1834400]",-0.0838507107926854,0.0330588013717769,0.0046856154984261,0.0039821313155062,-0.888113228103288,0.0523888701814584,-0.8002086013377883,0.8824061534938161,0.1355720138317107,0.0898697626154065,0.4166564091004712,0.3606988956376236,0.250699270296303,1.0
34,404,404,2014-04-15,84.139999,84.370003,82.870003,83.790001,75.674034,2249400,0.0099018323527831,1.360000999999997,-0.0004771680668692,"['rt AT_USER breaking : novartis slams the brakes on rnai development efforts $nvs - URL', 'rt AT_USER breaking : novartis slams the brakes on rnai development efforts $nvs - URL']","[84.139999, 83.279999]","[84.370003, 83.989998]","[82.870003, 83.160004]","[83.790001, 83.830002]","[75.674034, 75.710152]","[2249400, 2669500]",0.9371573678262636,0.0254708434796424,0.0059748488842002,0.0011746841103007,-0.5780380449220569,-0.656921411936805,0.2567684543679036,0.2922644506224616,0.1819487187954692,0.0264619925573821,0.516257684357562,0.2735213639569996,0.2495474399168532,1.0
35,405,405,2014-04-16,84.449997,84.510002,84.010002,84.410004,76.233978,1024600,0.0103804737036226,1.740005999999994,0.0073994867239588,"['$nvs : alnylam coo critical of big pharma , fiercedrugdelivery reports URL']","[84.449997, 84.139999]","[84.510002, 84.370003]","[84.010002, 82.870003]","[84.410004, 83.790001]","[76.233978, 75.674034]","[1024600, 2249400]",2.60583349193192,0.0232888295679786,0.0111133365458884,0.0012417641900634,0.6578262450922621,-0.639973420817765,1.984230179224474,0.1225616895076356,0.3667919976583884,0.0279770337895665,0.679040206290977,0.248452354664155,0.3305653981007717,1.0
36,406,406,2014-04-17,84.349998,84.889999,84.129997,84.669998,76.468788,969600,0.0053698440667501,2.0,0.0030801325397402,"['$nvs : alnylam coo critical of big pharma , fiercedrugdelivery reports URL']","[84.349998, 84.449997]","[84.889999, 84.510002]","[84.129997, 84.010002]","[84.669998, 84.410004]","[76.468788, 76.233978]","[969600, 1024600]",0.7428896878771609,0.0247424763260035,0.0110489857700147,0.0018515130553987,0.6423491570513632,-0.4859184705090505,0.0556569404912225,0.2356168204597294,0.3644771515026695,0.0417485539715433,0.4973065035889048,0.2651532033116565,0.2921713530936936,1.0
37,407,407,2014-04-21,84.709999,85.5,84.5,85.459999,77.182274,1507200,0.0037938631233019,1.6699979999999923,0.0093303533560966,"['AT_USER $celg is a compelling cheap growth stock that would be accretive to $azn , $pfe , $nvs , $jnj $gild $amgn URL']","[84.709999, 84.349998]","[85.5, 84.889999]","[84.5, 84.129997]","[85.459999, 84.669998]","[77.182274, 76.468788]","[1507200, 969600]",0.7622056765657627,0.0247424763260035,0.0112699614777284,0.003541330113845,0.6954963093078854,-0.0589809265964257,0.075653409941042,0.2356168204597294,0.3724261584969638,0.0799140201941743,0.4991908149342554,0.2651532033116565,0.3041710492342625,1.0
38,408,408,2014-04-22,86.43,86.779999,86.18,86.559998,78.175728,2158600,0.0035061307855427,2.7699969999999894,0.0128715072884566,"['novartis announces billions of dollars in deals with gsk , eli lilly URL $nvs $gsk $lly', '$nvs : novartis , glaxo swap units ; lilly buying animal biz URL', ""rt AT_USER just confirmed $lly used mostly ex-us cash to buy $nvs animal health . deal won't be accretive till ' 16 so $nvs ah must …"", '$nvs [ $$] deals reshape novartis , glaxo URL', '$nvs - earnings and corporate deals lift us stocks -> URL stock stocks stockaction', ""rt AT_USER . you don't want to miss maria's interview at 10am et with novartis ceo joseph jimenez . $nvs AT_USER AT_USER"", 'no respite after easter , pharma mega mergers and swaps make a strong comeback $gsk , $nvs , $azn , $pfe', 'AT_USER $celg is a compelling cheap growth stock that would be accretive to $azn , $pfe , $nvs , $jnj $gild $amgn URL']","[86.43, 84.709999]","[86.779999, 85.5]","[86.18, 84.5]","[86.559998, 85.459999]","[78.175728, 77.182274]","[2158600, 1507200]",0.7954509786547684,0.0234402270221353,0.0112463784891547,0.0064938871084726,0.689824334332183,0.6869917958634638,0.1100699069834695,0.1343363926196598,0.3715778238856247,0.1465991762503342,0.5024339572302999,0.2501917497087418,0.3177006767687501,1.0
39,409,409,2014-04-23,86.919998,86.970001,86.07,86.169998,77.823502,1845800,0.0065803776539896,2.1499939999999924,-0.0045055453906085,"['$nvs : novartis reshapes portfolio via gsk , eli lilly deals URL', '$arry $nvs $gsk array biopharma : novartis to honor array-novartis agreement with binimetinib : full story URL', '$nvs : novartis , glaxo swap units ; lilly buying animal biz URL', 'novartis announces billions of dollars in deals with gsk , eli lilly URL $nvs $gsk $lly', '$nvs : novartis , glaxo swap units ; lilly buying animal biz URL', ""rt AT_USER just confirmed $lly used mostly ex-us cash to buy $nvs animal health . deal won't be accretive till ' 16 so $nvs ah must …"", '$nvs [ $$] deals reshape novartis , glaxo URL', '$nvs - earnings and corporate deals lift us stocks -> URL stock stocks stockaction', ""rt AT_USER . you don't want to miss maria's interview at 10am et with novartis ceo joseph jimenez . $nvs AT_USER AT_USER"", 'no respite after easter , pharma mega mergers and swaps make a strong comeback $gsk , $nvs , $azn , $pfe']","[86.919998, 86.43]","[86.970001, 86.779999]","[86.07, 86.18]","[86.169998, 86.559998]","[77.823502, 78.175728]","[1845800, 2158600]",0.7832148393508781,0.0292411621967426,0.011201920887406,0.0023319652555768,0.6791317792384833,-0.3645307254355957,0.0974027021244004,0.5854951643015213,0.3699785811864777,0.0525998364377918,0.5012402986252286,0.3168382990373539,0.310164253821713,1.0
40,410,410,2014-04-24,84.620003,84.860001,83.709999,84.589996,76.396538,2549900,0.0123739718743035,1.9700019999999936,-0.0183358713783422,"[""rt AT_USER $azn's first btd -> azd 9291 granted fda breakthrough therapy designation $clvs $nvs astellas nsclc lcsm URL"", '$nvs : novartis reshapes portfolio via gsk , eli lilly deals URL', '$arry $nvs $gsk array biopharma : novartis to honor array-novartis agreement with binimetinib : full story URL', '$nvs : novartis , glaxo swap units ; lilly buying animal biz URL']","[84.620003, 86.919998]","[84.860001, 86.970001]","[83.709999, 86.07]","[84.589996, 86.169998]","[76.396538, 77.823502]","[2549900, 1845800]",1.0145331430228486,0.0299514498644318,0.0054612610868004,0.0036514802359946,-0.7015617079885142,-0.0311511550970984,0.3368700919189564,0.6407366903744491,0.1634737785590312,0.0824018224952024,0.5238058380352589,0.3249987456993626,0.2736700461972138,1.0
41,411,411,2014-04-25,84.860001,84.910004,84.220001,84.470001,76.288162,1437000,0.0111187574277588,2.0899969999999968,-0.001418548358839,"[""rt AT_USER novartis hopes new copd study data will draw patients from glaxo's advair URL $nvs $gsk pharma by AT_USER"", '$nvs - novartis ag discusses q1 2014 results ( webcast ) -> URL stock stocks stockaction', ""rt AT_USER $azn's first btd -> azd 9291 granted fda breakthrough therapy designation $clvs $nvs astellas nsclc lcsm URL""]","[84.860001, 84.620003]","[84.910004, 84.860001]","[84.220001, 83.709999]","[84.470001, 84.589996]","[76.288162, 76.396538]","[1437000, 2549900]",1.6210009502692426,0.0234301777948667,0.0043654161555394,0.0003738725660976,-0.965124784735052,-0.8592489432574463,0.9647030843382232,0.1335548294933038,0.1240537033236955,0.0083752145903767,0.5829679233008508,0.2500762948207432,0.2413682840089165,1.0
42,412,412,2014-04-28,85.699997,85.720001,84.459999,85.360001,77.091957,2438200,0.0103200566576342,2.0899969999999968,0.010536284946889,"[""rt AT_USER novartis hopes new copd study data will draw patients from glaxo's advair URL $nvs $gsk pharma by AT_USER"", '$nvs - novartis ag discusses q1 2014 results ( webcast ) -> URL stock stocks stockaction']","[85.699997, 84.860001]","[85.720001, 84.910004]","[84.459999, 84.220001]","[85.360001, 84.470001]","[77.091957, 76.288162]","[2438200, 1437000]",1.4909036940092726,0.0152689421145961,0.0039616049081459,3.699480712964436e-05,-1.0622459482790751,-0.9443621584979226,0.8300226466838486,-0.5011726677272325,0.1095276793407135,0.0007666414215932,0.5702766891154476,0.1563124136574952,0.2092208558838124,1.0
43,413,413,2014-04-29,85.75,86.589996,85.739998,86.449997,78.076378,2229500,0.0123765157053363,1.979996,0.0127694000378466,['$nvs alk inhibitor approved for late stage nsclc URL'],"[85.75, 85.699997]","[86.589996, 85.720001]","[85.739998, 84.459999]","[86.449997, 85.360001]","[78.076378, 77.091957]","[2229500, 2438200]",0.5190087395778799,0.0095467561640957,0.0025911205092647,0.0001431375692146,-1.3918629173392978,-0.9175448590026036,-0.1761110841869521,-0.94620684015922,0.0602281876228623,0.0031639352475029,0.4754664923065874,0.090570608803878,0.1573573059952077,0.0
44,414,414,2014-04-30,86.449997,86.970001,86.25,86.940002,78.518913,2049100,0.0054105154047397,2.4700010000000105,0.0056680742279262,"['rt AT_USER novartis ag $nvs gains fda approval for lung cancer drug zykadia ™ URL pharma biotech', 'commented on : "" expected decision in avanir nuedexta patent litigation "" URL $avnr $act $ipxl $nvs', '$nvs alk inhibitor approved for late stage nsclc URL']","[86.449997, 85.75]","[86.970001, 86.589996]","[86.25, 85.739998]","[86.940002, 86.449997]","[78.518913, 78.076378]","[2049100, 2229500]",0.5496587138443133,0.0150574482758619,0.0030009757454946,0.0010698474795627,-1.293288106250717,-0.683408713278472,-0.144381345474786,-0.5176212743104052,0.0749716278550378,0.0240941984406601,0.4784564554493502,0.1538825753414946,0.1828512142716357,0.0
45,415,415,2014-05-01,86.910004,87.25,86.550003,87.0,78.573105,592000,0.0046244345556916,2.529999000000004,0.0006901081046672,"['$nvs glaxo misses on q1 earnings , shares down URL', 'rt AT_USER novartis ag $nvs gains fda approval for lung cancer drug zykadia ™ URL pharma biotech', 'commented on : "" expected decision in avanir nuedexta patent litigation "" URL $avnr $act $ipxl $nvs']","[86.910004, 86.449997]","[87.25, 86.970001]","[86.550003, 86.25]","[87.0, 86.940002]","[78.573105, 78.518913]","[592000, 2049100]",0.598851835484447,0.0108745076594034,0.0042979338274286,0.0050960760513838,-0.981355046440452,0.3338304778471165,-0.0934552049661898,-0.8429430187767774,0.12162620799539,0.1150288293785884,0.483255337800861,0.1058250553482067,0.2064338576307615,1.0
46,416,416,2014-05-02,87.580002,87.75,87.18,87.360001,78.898239,1299500,0.0043697264880298,2.0,0.0041379425287355,"['$nvs glaxo misses on q1 earnings , shares down URL']","[87.580002, 86.910004]","[87.75, 87.25]","[87.18, 86.550003]","[87.360001, 87.0]","[78.898239, 78.573105]","[1299500, 592000]",0.6526875936527452,0.0084408123289793,0.0044860238360479,0.0038435584415584,-0.9361172760563332,0.0173780018981284,-0.0377228730169845,-1.0322199134278796,0.1283922403775955,0.0867400165203527,0.4885071181543013,0.0778644953681682,0.1953759676051044,0.0
47,419,419,2014-05-07,88.099998,88.349998,87.809998,88.309998,79.756226,1532400,0.0030553130737087,1.3099979999999931,0.0073001028242294,['rt AT_USER article on hearing loss drugs via AT_USER $lly $nvs $gnvc URL'],"[88.099998, 88.260002]","[88.349998, 88.309998]","[87.809998, 87.589996]","[88.309998, 87.669998]","[79.756226, 79.178207]","[1532400, 2310200]",-0.1451607688623201,0.0151290403763375,0.0047748179204764,0.0033386003507553,-0.8666590386115626,-0.110201232782165,-0.8636785444466055,-0.5120533092943365,0.1387808311452613,0.0753352547669653,0.4106754966104526,0.1547050921103031,0.1948741686582456,0.0
48,420,420,2014-05-08,88.540001,88.559998,87.739998,87.910004,79.394966,2331100,0.0046607224241676,0.9499969999999962,-0.0045294305181616,['rt AT_USER article on hearing loss drugs via AT_USER $lly $nvs $gnvc URL'],"[88.540001, 88.099998]","[88.559998, 88.349998]","[87.739998, 87.809998]","[87.910004, 88.309998]","[79.394966, 79.756226]","[2331100, 1532400]",-0.3532187615528609,0.0171925792470273,0.0037810218037658,0.0024851094630845,-1.1056782234496985,-0.3258383643359278,-1.0790661884185762,-0.3515647614661475,0.1030316876562855,0.0560586842755576,0.3903790446691137,0.178412949722459,0.181970591580854,0.0
49,422,422,2014-05-12,88.699997,88.709999,88.339996,88.610001,80.027161,2628600,0.0045373605292418,0.9400029999999902,0.0022621535001852,"['rt AT_USER the cover line on our story is "" will this man cure cancer , "" about $nvs ceo joe jimenez . what do people think of that ? askforbes', 'rt AT_USER the cover line on our story is "" will this man cure cancer , "" about $nvs ceo joe jimenez . what do people think of that ? askforbes', 'rt AT_USER the cover line on our story is "" will this man cure cancer , "" about $nvs ceo joe jimenez . what do people think of that ? askforbes']","[88.699997, 88.489998]","[88.709999, 88.690002]","[88.339996, 88.169998]","[88.610001, 88.410004]","[80.027161, 79.846542]","[2628600, 2691700]",-0.9056237801034684,0.0165027578105261,0.0051611708217184,0.0012449564337828,-0.7737368044008172,-0.6391668904976224,-1.6509318203286047,-0.4052145580255044,0.1526788380620105,0.0280491324047616,0.3364908870156701,0.1704876381973525,0.1719266239199487,0.0
50,423,423,2014-05-13,88.610001,88.699997,88.309998,88.470001,79.900726,1314500,0.0038588212735739,0.6999969999999962,-0.0015799570976192,"['$nvs - twitter chat : a look at using immune cells to battle cancer -> URL stock stocks stockaction', 'rt AT_USER the cover line on our story is "" will this man cure cancer , "" about $nvs ceo joe jimenez . what do people think of that ? askforbes', 'rt AT_USER the cover line on our story is "" will this man cure cancer , "" about $nvs ceo joe jimenez . what do people think of that ? askforbes', 'rt AT_USER the cover line on our story is "" will this man cure cancer , "" about $nvs ceo joe jimenez . what do people think of that ? askforbes']","[88.610001, 88.699997]","[88.699997, 88.709999]","[88.309998, 88.339996]","[88.470001, 88.610001]","[79.900726, 80.027161]","[1314500, 2628600]",-0.5489559355251645,0.0095419620668622,0.0057681546045712,0.0002166076977774,-0.6277503525039712,-0.8989824021480215,-1.281698964955707,-0.9465796936654368,0.1745134477810632,0.0048232993165424,0.3712845119703803,0.0905155297471154,0.1602841972037753,0.0
51,424,424,2014-05-14,89.220001,89.519997,89.050003,89.239998,80.596138,2354200,0.0038242832851637,1.3299939999999992,0.0087034813077486,"[""rt AT_USER soriot asked why $pfe's price ( 4x sales ) does not reflect company's value - cites price paid by $nvs for $gsk's oncology unit …"", '$nvs - twitter chat : a look at using immune cells to battle cancer -> URL stock stocks stockaction']","[89.220001, 88.610001]","[89.519997, 88.699997]","[89.050003, 88.309998]","[89.239998, 88.470001]","[80.596138, 79.900726]","[2354200, 1314500]",-0.0909804913320533,0.0095419620668622,0.004895771766001,0.0019252899012407,-0.8375682733386826,-0.4672785205783966,-0.8075895561021447,-0.9465796936654368,0.1431318205549548,0.0434148454223966,0.4159608854813195,0.0905155297471154,0.1732557703014466,0.0
52,425,425,2014-05-15,89.379997,89.959999,89.230003,89.93,81.219307,4580200,0.0041647812807125,1.519996000000006,0.0077319813476464,"[""rt AT_USER soriot asked why $pfe's price ( 4x sales ) does not reflect company's value - cites price paid by $nvs for $gsk's oncology unit …""]","[89.379997, 89.220001]","[89.959999, 89.519997]","[89.230003, 89.050003]","[89.93, 89.239998]","[81.219307, 80.596138]","[4580200, 2354200]",0.5475569725376617,0.0101032889514304,0.0042802373411249,0.0039809571783732,-0.9856112511686512,0.0520922207771492,-0.1465571287860841,-0.902923362379001,0.1209896244774189,0.0898432440695874,0.4782514265971925,0.0969645761121928,0.1965122178140979,0.0
53,427,427,2014-05-19,89.389999,89.550003,89.139999,89.519997,80.849022,1882900,0.005386010535721,1.4599990000000105,-0.0040053405876281,['$nvs : [ video ] pharmas mega mergers not necessarily good medicine URL'],"[89.389999, 90.0]","[89.550003, 90.010002]","[89.139999, 89.5]","[89.519997, 89.879997]","[80.849022, 81.174141]","[1882900, 2671800]",0.5787045404609896,0.0134710032898294,0.0036884960238825,0.0003885080920437,-1.1279317180169943,-0.8555512320347637,-0.1143122667468689,-0.6410045822936259,0.0997033214795029,0.0087057661541418,0.4812899309452841,0.135656016892511,0.1813387588678599,0.0
54,428,428,2014-05-20,88.970001,89.239998,88.730003,89.080002,80.451637,1522200,0.0049802871861806,0.8499980000000136,-0.0049150470816036,['$nvs : [ video ] pharmas mega mergers not necessarily good medicine URL'],"[88.970001, 89.389999]","[89.239998, 89.550003]","[88.730003, 89.139999]","[89.080002, 89.519997]","[80.451637, 80.849022]","[1522200, 1882900]",0.7020937834299278,0.0088278133607736,0.0034766539997876,0.0005006784774098,-1.1788821162548342,-0.82721103474029,0.0134238417817458,-1.0021215060351871,0.0920828741975892,0.0112391972332466,0.4933267857068417,0.082310723877772,0.1697398952538624,0.0
55,432,432,2014-05-27,90.239998,90.43,89.93,90.279999,81.5354,2354200,0.0018206980908002,1.1999970000000104,0.000775967196275,['$nvs - 3 stocks that soared stupendously last week -> URL stock stocks stockaction'],"[90.239998, 90.040001]","[90.43, 90.400002]","[89.93, 89.900002]","[90.279999, 90.209999]","[81.5354, 81.472183]","[2354200, 2267000]",1.1364552097135374,0.01440151938799,0.0055202262001821,9.750207850509843e-05,-0.6873799325746278,-0.9290748078934477,0.463087337183646,-0.5686351302587211,0.1655948899858934,0.0021332320891219,0.5356995669671578,0.1463466530003911,0.212443585510641,1.0
56,433,433,2014-05-28,90.160004,90.260002,89.870003,89.889999,81.183174,2061100,0.0035604251831102,0.7900010000000037,-0.0043198937120059,['$nvs - 3 stocks that soared stupendously last week -> URL stock stocks stockaction'],"[90.160004, 90.239998]","[90.260002, 90.43]","[89.870003, 89.93]","[89.889999, 90.279999]","[81.183174, 81.5354]","[2061100, 2354200]",1.3804173785959144,0.0194482356524595,0.0055536285629142,0.0010468161809088,-0.6793462872648431,-0.6892276426301824,0.7156440214732191,-0.1761345691644371,0.166796450183304,0.0235740236404087,0.5594985394180302,0.2043280326130749,0.2385492614637044,1.0
57,435,435,2014-05-30,89.459999,90.099998,89.360001,90.059998,81.336708,4092800,0.0026869477407969,0.3900000000000005,-0.001109205807045,['$nvs - supreme court + risky drug launch = billions at stake -> URL stock stocks stockaction'],"[89.459999, 90.25]","[90.099998, 90.269997]","[89.360001, 89.910004]","[90.059998, 90.160004]","[81.336708, 81.427025]","[4092800, 543200]",1.4742774994447054,0.0064450473440739,0.0061634450827412,0.0028703007228643,-0.5326785301474904,-0.2285185926097485,0.8128107298083067,-1.1874374519890727,0.1887329599992221,0.0647584449632,0.56865477229032,0.0549352873161546,0.2192703661422242,1.0
58,436,436,2014-06-02,89.059998,89.059998,88.489998,88.879997,80.271004,1841400,0.005955115777156,1.4000020000000006,-0.0131023875883273,"['$nvs ’ lbh 589 ( panobinostat ) meets primary endpoint in phase_iii for multiple_myeloma as combination with velcade URL', '$nvs - supreme court + risky drug launch = billions at stake -> URL stock stocks stockaction']","[89.059998, 89.459999]","[89.059998, 90.099998]","[88.489998, 89.360001]","[88.879997, 90.059998]","[80.271004, 81.336708]","[1841400, 4092800]",0.6381617300233817,0.0075757460973371,0.0030055241216137,0.0063793094165167,-1.2921941704483488,0.6580433850598669,-0.0527604666384911,-1.0994991032039612,0.0751352434576644,0.144011374801442,0.4870900925969207,0.0679258083212885,0.1935406297943289,0.0
59,437,437,2014-06-03,89.010002,89.080002,88.580002,88.879997,80.271004,1687300,0.0061696061277779,1.2800069999999977,0.0,['$nvs ’ lbh 589 ( panobinostat ) meets primary endpoint in phase_iii for multiple_myeloma as combination with velcade URL'],"[89.010002, 89.059998]","[89.080002, 89.059998]","[88.580002, 88.489998]","[88.879997, 88.879997]","[80.271004, 80.271004]","[1687300, 1841400]",-0.8972465568990429,0.0236318063403028,0.0068072281841875,0.004517445136645,-0.3778414267086255,0.1876375746948436,-1.6422594768838985,0.1492361781305277,0.2118913262701216,0.101960125567456,0.3373081010336069,0.2523927914536112,0.2258880860811989,1.0
60,451,451,2014-06-23,90.519997,90.540001,90.120003,90.470001,81.706993,746300,0.004548491253827,1.1200019999999995,-0.0056056494084749,['AT_USER AT_USER opinions on long term viability of juno and $kite compared to big pharma $nvs now $gsk $pfe in t cell therapy ?'],"[90.519997, 90.760002]","[90.540001, 91.089996]","[90.120003, 90.68]","[90.470001, 90.980003]","[81.706993, 82.167595]","[746300, 984200]",-0.1279803564862411,0.0037697859237213,0.001714867940148,0.0026450440164971,-1.602611552055071,-0.2854304011901895,-0.8458928852835159,-1.395501776103134,0.0287073572440707,0.0596708958848501,0.4123514784346266,0.0241993909732804,0.131232280634207,0.0
61,452,452,2014-06-24,90.879997,90.889999,90.470001,90.529999,81.761192,877200,0.0038152478492715,0.5800009999999958,0.0006631811576967,"['AT_USER with $cycc its always "" next week "" - btw : they are presenting @ jmp "" next hour "" - URL $nvs sapacitabine', 'AT_USER AT_USER opinions on long term viability of juno and $kite compared to big pharma $nvs now $gsk $pfe in t cell therapy ?']","[90.879997, 90.519997]","[90.889999, 90.540001]","[90.470001, 90.120003]","[90.529999, 90.470001]","[81.761192, 81.706993]","[877200, 746300]",0.8744885983820592,0.0141922493803691,0.0044849701269939,0.0009794372372604,-0.9363707049789348,-0.7062511426409613,0.1918919339965547,-0.5849107818125227,0.1283543360272629,0.0220522323997083,0.5101442269950323,0.1439423641286662,0.2011232898876674,1.0
62,453,453,2014-06-25,90.040001,90.379997,89.959999,90.339996,81.589592,1258300,0.0027647808871058,0.6400069999999971,-0.0020987849563546,"['thanks to alcon for for the activity on their board . add to the conversation | URL AT_USER $nvs', 'AT_USER with $cycc its always "" next week "" - btw : they are presenting @ jmp "" next hour "" - URL $nvs sapacitabine']","[90.040001, 90.879997]","[90.379997, 90.889999]","[89.959999, 90.470001]","[90.339996, 90.529999]","[81.589592, 81.761192]","[1258300, 877200]",1.4405587663572834,0.0144139701870723,0.0041355053141048,0.0003874506411391,-1.0204209375184212,-0.8558184002999683,0.7779041233208466,-0.5676667885946017,0.1157832789157984,0.00868188303225,0.5653654459021258,0.1464896993834728,0.2090800768084117,1.0
63,454,454,2014-06-26,90.010002,90.339996,89.580002,90.190002,81.454124,1178500,0.0022472577851555,0.7900009999999895,-0.0016603277246104,['thanks to alcon for for the activity on their board . add to the conversation | URL AT_USER $nvs'],"[90.010002, 90.040001]","[90.339996, 90.379997]","[89.580002, 89.959999]","[90.190002, 90.339996]","[81.454124, 81.589592]","[1178500, 1258300]",0.7947489708084828,0.0122814896751987,0.0039465765212203,0.0018388431895951,-1.0658604449871911,-0.4891195515733316,0.1093431681828785,-0.7335171660619779,0.1089870735247143,0.0414623979447973,0.5023654750329551,0.1219897759488846,0.1937011806128379,0.0
64,457,457,2014-07-01,91.260002,91.660004,91.110001,91.470001,82.610138,713900,0.0044162517611235,1.2799989999999897,0.0103833205609555,['[ $$] japan prosecutors charge novartis unit over research .. URL $nvs biotech stocks'],"[91.260002, 90.529999]","[91.660004, 90.660004]","[91.110001, 90.209999]","[91.470001, 90.529999]","[82.610138, 81.761192]","[713900, 1151900]",1.1400871436616329,0.0220062674935075,0.0066281611180214,5.044242145409855e-05,-0.4209090775745238,-0.9409645768470156,0.4668472201183315,0.022812405520284,0.2054498699845906,0.0010703633349859,0.5360538690147666,0.2337170862995966,0.2440727971584849,1.0
65,458,458,2014-07-02,91.190002,91.529999,91.029999,91.489998,82.628197,477800,0.0039600802356561,1.299995999999993,0.0002186181237715,['[ $$] japan prosecutors charge novartis unit over research .. URL $nvs biotech stocks'],"[91.190002, 91.260002]","[91.529999, 91.660004]","[91.029999, 91.110001]","[91.489998, 91.470001]","[82.628197, 82.610138]","[477800, 713900]",0.990408443627272,0.0213360485255601,0.0064347069443974,0.0004557071297169,-0.4674369901972786,-0.8385731858290598,0.3118955062414242,-0.0293128393300007,0.1984908761878382,0.0102234941174681,0.5214524278367386,0.2260169862012875,0.2390459460858331,1.0
66,459,459,2014-07-03,91.059998,91.459999,90.949997,91.43,82.574013,803200,0.0043754422980412,1.110000999999997,-0.0006557875320971,['novartis starts shipping flucelvax ahead of upcoming flu season URL $nvs pharma vaccines by AT_USER'],"[91.059998, 91.190002]","[91.459999, 91.529999]","[90.949997, 91.029999]","[91.43, 91.489998]","[82.574013, 82.628197]","[803200, 477800]",1.1932107025052792,0.0086014748190842,0.006273202694229,0.000410220708832,-0.5062805855525486,-0.8500654717643377,0.5218422627541511,-1.019724636457993,0.192681194990391,0.0091961577847013,0.541236172972811,0.0797103357800564,0.2057059653819899,1.0
67,460,460,2014-07-07,90.419998,90.550003,90.199997,90.290001,81.544434,1211200,0.0081062679850631,1.1999969999999962,-0.0124685442414962,"['upenn / $nvs cart for adult + pediatric all gets breakthrough designation from fda .', 'time to take profits in novartis and astrazeneca ? .. URL $nvs biotech stocks', 'novartis starts shipping flucelvax ahead of upcoming flu season URL $nvs pharma vaccines by AT_USER']","[90.419998, 91.059998]","[90.550003, 91.459999]","[90.199997, 90.949997]","[90.290001, 91.43]","[81.544434, 82.574013]","[1211200, 803200]",1.1877507137404566,0.0081546361088461,0.0062563622936937,0.0026326644855201,-0.5103308919892634,-0.2885581282560828,0.516189924668213,-1.054476826851945,0.1920754068563611,0.0593912972330356,0.5407035407094097,0.0745766362561976,0.216686720263751,1.0
68,461,461,2014-07-08,90.400002,90.43,89.389999,89.519997,80.849022,1823100,0.0053658022380985,1.9700009999999963,-0.0085281204061565,"['upenn / $nvs cart for adult + pediatric all gets breakthrough designation from fda .', 'time to take profits in novartis and astrazeneca ? .. URL $nvs biotech stocks']","[90.400002, 90.419998]","[90.43, 90.550003]","[89.389999, 90.199997]","[89.519997, 90.290001]","[80.849022, 81.544434]","[1823100, 1211200]",1.119863146093478,0.0081546361088461,0.004791482581671,0.0026188219681543,-0.862650999470173,-0.2920554833905825,0.4459107536477609,-1.054476826851945,0.1393802975289828,0.0590786562129205,0.5340809796804245,0.0745766362561976,0.2017791424196313,1.0
69,466,466,2014-07-15,90.589996,90.75,89.949997,90.139999,81.408966,1031000,0.0046398777651229,0.7300029999999964,-0.0012188476454293,"['rt AT_USER novartis , google to make blood sugar-tracking contact lens URL AT_USER $nvs $goog URL']","[90.589996, 90.230003]","[90.75, 90.43]","[89.949997, 90.110001]","[90.139999, 90.25]","[81.408966, 81.508308]","[1031000, 629400]",0.9786207498591176,0.0170563878578604,0.0082287419963928,0.000323540998183,-0.0359513076829292,-0.8719653706833171,0.2996925451546941,-0.3621568363645444,0.2630264639403031,0.0072384478939019,0.5203025159445268,0.1768482561234035,0.2418539209755338,1.0
70,467,467,2014-07-16,90.440002,90.440002,89.980003,90.040001,81.318657,843400,0.0044018277714128,0.7300029999999964,-0.0011093632250872,"['rt AT_USER novartis , google to make blood sugar-tracking contact lens URL AT_USER $nvs $goog URL']","[90.440002, 90.589996]","[90.440002, 90.75]","[89.980003, 89.949997]","[90.040001, 90.139999]","[81.318657, 81.408966]","[843400, 1031000]",1.0019784784373846,0.0082458263667211,0.0082216386826526,0.0007775610097289,-0.0376597348253615,-0.7572558004089985,0.3238731404875185,-1.0473846454201778,0.2627709413256786,0.0174927445518997,0.5225811066846229,0.0756243149212443,0.2196172768708614,1.0
71,468,468,2014-07-17,88.389999,89.150002,88.129997,88.529999,79.954903,2275400,0.0089971839806526,1.7200009999999963,-0.0167703463264066,"['rt AT_USER novartis offloads share of lts lohmann to sap billionaire hopp , gaining $400m URL $nvs pharma by AT_USER', 'novartis cites momentum in 3 percent profit rise .. URL $nvs biotech stocks']","[88.389999, 90.440002]","[89.150002, 90.440002]","[88.129997, 89.980003]","[88.529999, 90.040001]","[79.954903, 81.318657]","[2275400, 843400]",0.5685179407176287,0.0075629984225306,0.0038510953803035,0.0020128604529086,-1.0888247372455344,-0.4451535479008558,-0.124857729050119,-1.1004905339189044,0.1055523961802065,0.0453926754573539,0.4802962088129924,0.0677793511532209,0.1747551579009434,0.0
72,469,469,2014-07-18,88.589996,89.010002,88.349998,88.82,80.216827,1530500,0.0076758615034551,1.7200009999999963,0.0032757370752933,"['$nvs : alzheimers rates falling , but pharmas search for a cure yields no resu ... URL', 'some thoughts from leerink on changes in the copd market $gsk $azn $thrx $nvs URL', 'rt AT_USER novartis offloads share of lts lohmann to sap billionaire hopp , gaining $400m URL $nvs pharma by AT_USER', 'novartis cites momentum in 3 percent profit rise .. URL $nvs biotech stocks']","[88.589996, 88.389999]","[89.010002, 89.150002]","[88.349998, 88.129997]","[88.82, 88.529999]","[80.216827, 79.954903]","[1530500, 2275400]",1.3784237543348914,0.0096142739683622,0.005172255215574,0.0026226369615696,-0.7710708825489994,-0.2910916134197892,0.713580164050612,-0.9409557472366736,0.1530775693306975,0.0591648199793491,0.5593040575888071,0.0913463162608936,0.2157231907899368,1.0
73,470,470,2014-07-21,88.449997,88.93,88.379997,88.589996,80.009094,1037600,0.0075741752725427,1.6099999999999994,-0.0025895519027245,"['rt AT_USER glaxo ’ s mek / braf combo spoils the exelixis party : $gsk $exel $arry $nvs $rhhby URL mekinist tafinlar', '$nvs : alzheimers rates falling , but pharmas search for a cure yields no resu ... URL', 'some thoughts from leerink on changes in the copd market $gsk $azn $thrx $nvs URL']","[88.449997, 88.589996]","[88.93, 89.010002]","[88.379997, 88.349998]","[88.589996, 88.82]","[80.009094, 80.216827]","[1037600, 1530500]",1.4987305435563734,0.0169762453107979,0.0057733784692343,0.0034414931491769,-0.626493954081313,-0.0842050467306376,0.8381252274204635,-0.3683897991548279,0.1747013622680168,0.0776591463403657,0.5710402131388727,0.1759275038558205,0.2498320564007689,1.0
74,471,471,2014-07-22,89.010002,89.410004,88.93,89.260002,80.614197,947300,0.0092371229592661,1.510002,0.0075629984225307,['rt AT_USER glaxo ’ s mek / braf combo spoils the exelixis party : $gsk $exel $arry $nvs $rhhby URL mekinist tafinlar'],"[89.010002, 88.449997]","[89.410004, 88.93]","[88.93, 88.379997]","[89.260002, 88.589996]","[80.614197, 80.009094]","[947300, 1037600]",-0.1529217570494354,0.0154950443942706,0.0049779651382158,0.0029743407393836,-0.8177998394561823,-0.2022325583320383,-0.8717129436008999,-0.4835879122176483,0.1460885061444251,0.0671082471009061,0.4099183974876548,0.1589100873570049,0.1955063095224977,0.0
75,475,475,2014-07-28,88.160004,88.160004,87.5,87.769997,79.268524,1185600,0.0037583874861558,1.4900049999999965,-0.00723907896215,['$nvs 1:44 am novartis unit alcon receives simbrinza URL'],"[88.160004, 88.769997]","[88.160004, 88.769997]","[87.5, 88.209999]","[87.769997, 88.410004]","[79.268524, 79.846542]","[1185600, 693200]",0.7396620204936792,0.0177215185794818,0.0078517687763817,0.0024917207195824,-0.1266176226722631,-0.3241680097864329,0.0523155659818216,-0.3104273220117322,0.2494658658386681,0.0562080032123612,0.4969916385117007,0.1844898977060501,0.246788851317195,1.0
76,476,476,2014-07-29,88.519997,88.57,88.120003,88.209999,79.665909,843500,0.0055725748294013,1.3599999999999994,0.0050131253849763,['$nvs 1:44 am novartis unit alcon receives simbrinza URL'],"[88.519997, 88.160004]","[88.57, 88.160004]","[88.120003, 87.5]","[88.209999, 87.769997]","[79.665909, 79.268524]","[843500, 1185600]",0.7385311447317183,0.0229007983217766,0.0072231486923145,0.0029073793342725,-0.2778078492591286,-0.2191505659306578,0.0511448507266953,0.0923831587809019,0.2268529483523799,0.0655958862023025,0.4968813194354785,0.2439942900913518,0.2583311110203782,1.0
77,478,478,2014-07-31,87.790001,88.0,86.940002,86.940002,78.518913,1077500,0.0087594359711218,1.5,-0.0169606509054579,['icymi : novartis reports high bexsero uptake as it pushes ahead in open market : URL $nvs pharma vaccines'],"[87.790001, 88.57]","[88.0, 88.629997]","[86.940002, 88.0]","[86.940002, 88.440002]","[78.518913, 79.873627]","[1077500, 1010900]",0.5613445618360988,0.0208797536656891,0.0042279694048263,0.0005711049313215,-0.9981822798909348,-0.8094175717679238,-0.132283818077658,-0.0648004671534032,0.1191094259908359,0.0128298182028432,0.4795964320928423,0.2207746456180137,0.2080775804761337,1.0
78,479,479,2014-08-01,86.089996,87.360001,86.089996,86.900002,78.482796,1378600,0.0086575093977988,1.5400000000000065,-0.0004600874060252,['icymi : novartis reports high bexsero uptake as it pushes ahead in open market : URL $nvs pharma vaccines'],"[86.089996, 87.790001]","[87.360001, 88.0]","[86.089996, 86.940002]","[86.900002, 86.940002]","[78.482796, 78.518913]","[1378600, 1077500]",0.5133579543774119,0.0208797536656891,0.0045338300810298,0.0008073743317605,-0.924619334462873,-0.7497233717236411,-0.1819609402543937,-0.0648004671534032,0.1301119415142672,0.0181660951547322,0.4749152474888854,0.2207746456180137,0.2109919824439746,1.0
79,484,484,2014-08-08,84.660004,85.519997,84.419998,85.349998,77.082932,1061500,0.0042183129736465,1.7799990000000037,0.0011729970674487,['rt : AT_USER our anti pd1 clinical trial for relapsed hodgkin lymphoma is now open ... $bmy $mrk $azn $nvs URL'],"[84.660004, 85.519997]","[85.519997, 85.669998]","[84.419998, 85.160004]","[85.349998, 85.25]","[77.082932, 76.992615]","[1061500, 1141500]",0.5450375814532209,0.0198505023336116,0.0044255865462473,0.0040960493067546,-0.9506531265180757,0.0811706055462144,-0.149165275211532,-0.1448488994759449,0.1262181713619932,0.0924426643537392,0.4780056552167926,0.2089496471289577,0.2264040345153707,1.0
80,485,485,2014-08-11,86.110001,86.169998,85.589996,85.639999,77.344841,875800,0.0052865587661049,1.2099989999999965,0.0033977856683722,['rt : AT_USER our anti pd1 clinical trial for relapsed hodgkin lymphoma is now open ... $bmy $mrk $azn $nvs URL'],"[86.110001, 84.660004]","[86.169998, 85.519997]","[85.589996, 84.419998]","[85.639999, 85.349998]","[77.344841, 77.082932]","[875800, 1061500]",0.5101265043716511,0.0150812418241731,0.0045628572425638,0.0032524864079548,-0.9176379744320188,-0.1319581886917482,-0.1853062306436424,-0.5157707678477536,0.1311561156112554,0.0733903230604101,0.4746000134097009,0.1541559377983216,0.208325597469922,1.0
81,491,491,2014-08-19,88.230003,88.760002,88.059998,88.629997,80.045219,891700,0.006398886516747,1.9599989999999965,0.0129142514285713,['$nvs novartis & 39 ; new heart drug expected to be a hit URL'],"[88.230003, 87.230003]","[88.760002, 87.620003]","[88.059998, 87.230003]","[88.629997, 87.5]","[80.045219, 79.024681]","[891700, 587000]",0.1547032445100468,0.0125282282737748,0.0026380643632826,0.000687601861584,-1.380572390508042,-0.7799842594273783,-0.5532506559668853,-0.714327452729656,0.0619168665631325,0.0154609667255487,0.439927800055491,0.1248245389114595,0.160532543063908,0.0
82,492,492,2014-08-20,88.449997,88.949997,88.339996,88.599998,80.018127,503800,0.0066769816007094,1.6999969999999962,-0.0003384745686045,['$nvs novartis & 39 ; new heart drug expected to be a hit URL'],"[88.449997, 88.230003]","[88.949997, 88.760002]","[88.339996, 88.059998]","[88.599998, 88.629997]","[80.018127, 80.045219]","[503800, 891700]",0.2188222723147633,0.0118044186106043,0.0022465464841227,0.0017557730297827,-1.4747368602144637,-0.510107486229018,-0.4868727862487417,-0.7706206311118073,0.047833063451772,0.039586211784537,0.4461827328727054,0.1165087389638615,0.162527686768219,0.0
83,496,496,2014-08-26,89.489998,89.949997,89.43,89.709999,81.020607,1034400,0.0025026701813554,1.110000999999997,0.0067332285183119,['rt AT_USER $nvs - kol survey results on novartis lcz 696 paradigm-hf data at esccongress [ via ms ] cc : AT_USER URL'],"[89.489998, 88.830002]","[89.949997, 89.480003]","[89.43, 88.830002]","[89.709999, 89.110001]","[81.020607, 80.478729]","[1034400, 783600]",-1.470995751971524,0.049927514211718,0.0167785462869324,0.0018703758164325,2.020373141253786,-0.4811527351728326,-2.236221216874745,2.194344235138914,0.5705826872397431,0.0421745800111686,0.2813377784635383,0.5545023891361414,0.3621493587126478,1.0
84,497,497,2014-08-27,90.25,90.279999,89.800003,90.0,81.282524,1118100,0.002462212650986,1.0500030000000038,0.0032326496849031,['rt AT_USER $nvs - kol survey results on novartis lcz 696 paradigm-hf data at esccongress [ via ms ] cc : AT_USER URL'],"[90.25, 89.489998]","[90.279999, 89.949997]","[89.800003, 89.43]","[90.0, 89.709999]","[81.282524, 81.020607]","[1118100, 1034400]",0.3043113308270496,0.049927514211718,0.0184585980298888,0.0025922366140694,2.4244445512090604,-0.2987723559184826,-0.3983720434499266,2.194344235138914,0.631018031892375,0.0584782110769974,0.4545223527314133,0.5545023891361414,0.4246302462092317,2.0
85,500,500,2014-09-02,92.949997,93.720001,92.870003,93.709999,84.633163,5559900,0.0181927823412124,4.0,0.0430766158983355,"['rt AT_USER study results give novartis a reason to have heart .. URL pharma $nvs', 'volumeshiftup $uthr $hov $ge $amgn $dis $exel $exas $nvs $mc $bac quantheta']","[92.949997, 89.790001]","[93.720001, 89.989998]","[92.870003, 89.510002]","[93.709999, 89.839996]","[84.633163, 81.138023]","[5559900, 952000]",-0.4241892967902283,0.0100782891630198,0.0054871240167093,0.0101758200962846,-0.695341381383886,1.617243635144019,-1.1525369365428386,-0.9048676823019342,0.1644041279303076,0.2297576982796555,0.3834557343022834,0.0966773552449772,0.2185737289393059,1.0
86,501,501,2014-09-03,94.620003,94.660004,94.150002,94.209999,85.08474,1612600,0.0179933434907977,4.479996,0.0053356099171444,"['rt AT_USER study results give novartis a reason to have heart .. URL pharma $nvs', 'volumeshiftup $uthr $hov $ge $amgn $dis $exel $exas $nvs $mc $bac quantheta']","[94.620003, 92.949997]","[94.660004, 93.720001]","[94.150002, 92.870003]","[94.209999, 93.709999]","[85.08474, 84.633163]","[1612600, 5559900]",-0.2377761491170518,0.0079340090468749,0.0050054204724363,0.009291193053511,-0.8111965216382746,1.3937398570085875,-0.9595566613632924,-1.0716357557629967,0.1470761379796501,0.2097779002584162,0.4016406905447952,0.0720418669601615,0.2076341489357558,1.0
87,503,503,2014-09-05,92.849998,93.419998,92.730003,93.269997,84.235786,1398600,0.0196502958648008,4.370002999999997,-0.0006429336624249,['rt AT_USER $epgl lands exclusive deal with the cooper companies $coo ! direct competition to $goog $nvs wearabletech smartlens'],"[92.849998, 93.809998]","[93.419998, 93.889999]","[92.730003, 92.980003]","[93.269997, 93.330002]","[84.235786, 84.289978]","[1398600, 1569600]",0.2695297283212985,0.0115780661618574,0.0041751963055567,0.0089708673683232,-1.0108748060104298,1.312808574771473,-0.4343789630611621,-0.7882248431345259,0.1172110556244962,0.2025431649613796,0.4511293414148486,0.113908191088909,0.2211979382724083,1.0
88,504,504,2014-09-08,93.260002,93.599998,93.07,93.279999,84.24482,1287800,0.0052803219371261,0.9400019999999928,0.0001072370571642,['rt AT_USER $epgl lands exclusive deal with the cooper companies $coo ! direct competition to $goog $nvs wearabletech smartlens'],"[93.260002, 92.849998]","[93.599998, 93.419998]","[93.07, 92.730003]","[93.279999, 93.269997]","[84.24482, 84.235786]","[1287800, 1398600]",0.2970985812970632,0.0063993066041103,0.0043392920085107,0.0073107250164325,-0.9714079370058212,0.8933684379123811,-0.4058388901100037,-1.1909948673775654,0.1231139573688136,0.1650479186332948,0.4538187353298072,0.0544097750684647,0.199097596600095,0.0
89,505,505,2014-09-09,93.879997,94.25,93.699997,93.830002,84.741554,1120100,0.0054538051171455,0.9400019999999928,0.0058962586395394,['achillion - an options strategy for a potential acquisition URL $abbv $bmy $jnj $gild $mrk $idix $nvs $rhhby $achn'],"[93.879997, 93.260002]","[94.25, 93.599998]","[93.699997, 93.07]","[93.830002, 93.279999]","[84.741554, 84.24482]","[1120100, 1287800]",0.543830081295305,0.0066125745176498,0.0038889514805245,0.0006808220681423,-1.0797199177923014,-0.7816971953607482,-0.1504153142547142,-1.1744082848670745,0.106914167609957,0.0153078412873232,0.4778878612853633,0.0568599956091351,0.1642424664479446,0.0
90,506,506,2014-09-10,93.610001,94.099998,93.540001,94.010002,84.904114,776900,0.002524127290063,0.7400049999999965,0.0019183629560191,"['$kite AT_USER $nvs latest car findings put into perspective : interview with nci chief of surgery URL', 'achillion - an options strategy for a potential acquisition URL $abbv $bmy $jnj $gild $mrk $idix $nvs $rhhby $achn']","[93.610001, 93.879997]","[94.099998, 94.25]","[93.540001, 93.699997]","[94.010002, 93.830002]","[84.904114, 84.741554]","[776900, 1120100]",0.582986229834323,0.0102388969658937,0.0040096220550953,0.0008240521411536,-1.0506972823816003,-0.7455096712259789,-0.1098797382272181,-0.8923766585469555,0.1112549671086584,0.0185427728358328,0.4817076178674244,0.0985225673589912,0.1775069812927267,0.0
91,507,507,2014-09-11,94.139999,94.449997,93.989998,94.360001,85.220207,948200,0.0021393217768834,1.090003999999993,0.0037229974742474,['$kite AT_USER $nvs latest car findings put into perspective : interview with nci chief of surgery URL'],"[94.139999, 93.610001]","[94.449997, 94.099998]","[93.989998, 93.540001]","[94.360001, 94.010002]","[85.220207, 84.904114]","[948200, 776900]",0.4900619976952667,0.0110921605995699,0.0038547806716102,0.0019023072570334,-1.0879383830837432,-0.4730851572326059,-0.2060775875360171,-0.8260153975945408,0.1056849646271007,0.0428957695101159,0.4726426827144576,0.1083256551612888,0.1823872680032408,0.0
92,508,508,2014-09-12,93.769997,93.870003,93.379997,93.760002,84.678322,1080300,0.0046408226406062,1.0800019999999932,-0.0063586158715703,['potential novartis ag $nvs trade has 4.03 % downside protection ( URL )'],"[93.769997, 94.139999]","[93.870003, 94.449997]","[93.379997, 93.989998]","[93.760002, 94.360001]","[84.678322, 85.220207]","[1080300, 948200]",0.4331664871486198,0.009584674982222,0.005057910058713,0.0015075666452543,-0.7985721835940948,-0.5728176024894258,-0.2649774635309364,-0.9432577626579968,0.1489643097282918,0.033980331350551,0.4670924177111538,0.0910062555240481,0.1852608285785112,0.0
93,509,509,2014-09-15,93.639999,94.389999,93.550003,94.18,85.057648,684200,0.004320990070271,0.5999989999999968,0.0044795007576898,['potential novartis ag $nvs trade has 4.03 % downside protection ( URL )'],"[93.639999, 93.769997]","[94.389999, 93.870003]","[93.550003, 93.379997]","[94.18, 93.760002]","[85.057648, 84.678322]","[684200, 1080300]",0.1199181769473309,0.009584674982222,0.0047103482711239,0.0023077770505537,-0.8821647170660522,-0.3706419507854642,-0.5892611627051819,-0.9432577626579968,0.1364617088357327,0.0520535322581879,0.4365344507160451,0.0910062555240481,0.1790139868335034,0.0
94,510,510,2014-09-16,93.940002,94.599998,93.699997,94.379997,85.238274,819700,0.0043335607980417,0.619995000000003,0.0021235612656613,['novartis presents positive data on lucentis and jetrea .. URL $nvs biotech stocks'],"[93.940002, 93.639999]","[94.599998, 94.389999]","[93.699997, 93.550003]","[94.379997, 94.18]","[85.238274, 85.057648]","[819700, 684200]",0.2092138999845211,0.014880622422412,0.0051663018066959,0.0005039554894356,-0.7725027445910463,-0.8263830874434663,-0.4968196508313222,-0.5313736318946207,0.1528634114519806,0.0113132103881953,0.4452454179216507,0.1518510351484393,0.1903182687275665,0.0
95,511,511,2014-09-17,95.050003,95.5,94.610001,94.720001,85.545341,1045000,0.0043148960893925,0.9599989999999964,0.0036025006442836,"['novartis ag reaches new 52 - week high at $95.18 $nvs URL', 'novartis presents positive data on lucentis and jetrea .. URL $nvs biotech stocks']","[95.050003, 93.940002]","[95.5, 94.599998]","[94.610001, 93.699997]","[94.720001, 94.379997]","[85.545341, 85.238274]","[1045000, 819700]",0.2252017920514694,0.014880622422412,0.0047232364502454,0.0010799714805259,-0.8790649644952079,-0.680850852896963,-0.4802685231392462,-0.5313736318946207,0.136925326429904,0.0243228546818003,0.4468050671270662,0.1518510351484393,0.1899760708468024,0.0
96,512,512,2014-09-18,94.18,94.800003,94.150002,94.800003,85.617592,769600,0.0013873798972717,1.0400010000000035,0.0008446157005426,"['rt AT_USER novartis ag $nvs discloses more layoffs at new york plant --> URL pharma biotech', 'novartis ag reaches new 52 - week high at $95.18 $nvs URL']","[94.18, 95.050003]","[94.800003, 95.5]","[94.150002, 94.610001]","[94.800003, 94.720001]","[85.617592, 85.545341]","[769600, 1045000]",0.1606847996389205,0.0118330358415773,0.0045486400957043,0.0001479256027656,-0.921057358746308,-0.9163351474103236,-0.5470583773149768,-0.7683949701819576,0.1306446919756244,0.0032720756712547,0.4405113121072881,0.116837520382423,0.1728164000341475,0.0
97,513,513,2014-09-19,93.839996,94.169998,93.639999,93.900002,84.804764,2460700,0.0051701309168287,0.9000010000000032,-0.0094936811341662,['rt AT_USER novartis ag $nvs discloses more layoffs at new york plant --> URL pharma biotech'],"[93.839996, 94.18]","[94.169998, 94.800003]","[93.639999, 94.150002]","[93.900002, 94.800003]","[84.804764, 85.617592]","[2460700, 769600]",0.2939877377897316,0.0118330358415773,0.0040827809675709,0.0008845502544932,-1.03310173805462,-0.7302246344277916,-0.4090593251682533,-0.7683949701819576,0.1138866622980543,0.0199091566639842,0.4535152666433747,0.116837520382423,0.1760371514969591,0.0
98,523,523,2014-10-03,91.959999,92.650002,91.900002,92.370003,83.422966,1611900,0.0060470482456508,1.759994000000006,-0.0072011822097896,['dewdiligence : could be . $nvs has a modest-selling hbv drug : dewdiligence URL'],"[91.959999, 93.959999]","[92.650002, 93.959999]","[91.900002, 92.629997]","[92.370003, 93.040001]","[83.422966, 84.028061]","[1611900, 1801700]",1.0132766344290989,0.0558785937762892,0.0152207018366624,0.0018454446606679,1.6456939647637243,-0.4874516693419716,0.3355693179273472,2.6571802548009904,0.5145434213885719,0.0416114958722856,0.5236832632379289,0.6228739371401301,0.4256780294097291,2.0
99,524,524,2014-10-06,92.389999,92.769997,92.150002,92.589996,83.621651,1008100,0.0046896569082859,1.759994000000006,0.0023816498089752,"['$nvs and $bmy announce collaboration to test nivolumab in combination with zykadia , inc 280 ( $incy ) & egf 816 in lung cancer immunotherapy', 'icymi : AT_USER AT_USER partner to study lung cancer drugs in combo with opdivo URL $bmy pharma', 'dewdiligence : could be . $nvs has a modest-selling hbv drug : dewdiligence URL']","[92.389999, 91.959999]","[92.769997, 92.650002]","[92.150002, 91.900002]","[92.589996, 92.370003]","[83.621651, 83.422966]","[1008100, 1611900]",0.8200375338847572,0.0390383981462712,0.0143655131610961,0.0021606042601353,1.4400114342329808,-0.4078256147554394,0.1355226191618985,1.3474600551031022,0.4837803079502148,0.0487295522252439,0.5048324223417593,0.4293980759251404,0.3666850896105896,1.0
100,525,525,2014-10-07,90.459999,90.610001,89.68,89.730003,81.038681,2132600,0.0130583658118147,3.489998,-0.0308887906205331,"['AT_USER $gsk $nvs $oxgn URL read this ---> URL here comes a buyout or big deal', '$nvs and $bmy announce collaboration to test nivolumab in combination with zykadia , inc 280 ( $incy ) & egf 816 in lung cancer immunotherapy', 'icymi : AT_USER AT_USER partner to study lung cancer drugs in combo with opdivo URL $bmy pharma']","[90.459999, 92.389999]","[90.610001, 92.769997]","[89.68, 92.150002]","[89.730003, 92.589996]","[81.038681, 83.621651]","[2132600, 1008100]",0.657614542695516,0.0447795425999928,0.0106017552289354,0.0067902493073615,0.5347851632240237,0.7618686286364196,-0.0326223530486372,1.793968695835243,0.3483892351616238,0.1532926827662162,0.4889877513814649,0.4953576937316861,0.3715068407602478,1.0
101,526,526,2014-10-08,88.949997,90.830002,88.93,90.760002,81.96891,1345000,0.0159586379888375,3.309998000000008,0.0114788695593825,['AT_USER $gsk $nvs $oxgn URL read this ---> URL here comes a buyout or big deal'],"[88.949997, 90.459999]","[90.830002, 90.610001]","[88.93, 89.68]","[90.760002, 89.730003]","[81.96891, 81.038681]","[1345000, 2132600]",0.4143843195219361,0.032591022586511,0.0058575166954377,0.0076683621108252,-0.6062577608594797,0.9837265639171312,-0.2844213059975659,0.8460253811136653,0.1777280087510088,0.1731253530382678,0.4652601816232272,0.3553246170172436,0.2928595401074369,1.0
102,528,528,2014-10-10,88.419998,88.690002,87.690002,87.690002,79.196274,1678500,0.0156203185258383,4.899993999999992,-0.0150510728411891,['$nvs novartis presents data showing consistent efficacy of ain 457 in clearing skin of psoriasis patients at eadv'],"[88.419998, 90.339996]","[88.690002, 90.559998]","[87.690002, 88.879997]","[87.690002, 89.029999]","[79.196274, 80.406479]","[1678500, 1387700]",0.688484278734256,0.0274053291250997,0.0111848697341737,0.0038728967733094,0.675030784398994,0.0247904228094088,-0.0006651106017666,0.4427160832249225,0.3693652117907794,0.0874026392012366,0.4919991527020766,0.2957465378496194,0.311128385385928,1.0
103,529,529,2014-10-13,88.599998,88.800003,87.269997,87.349998,78.889206,2072300,0.0118856084943575,3.4100040000000007,-0.0038773405433382,['$nvs novartis presents data showing consistent efficacy of ain 457 in clearing skin of psoriasis patients at eadv'],"[88.599998, 88.419998]","[88.800003, 88.690002]","[87.269997, 87.690002]","[87.349998, 87.690002]","[78.889206, 79.196274]","[2072300, 1678500]",1.514793435093044,0.0338744425032148,0.0129956032449014,0.0039171481198304,1.1105326347440836,0.0359706633591597,0.8547539967300221,0.9458413824554358,0.4345014817025203,0.0884020806866398,0.5726071786848582,0.3700697410728169,0.3663951205367088,1.0
104,530,530,2014-10-14,87.370003,87.839996,86.800003,86.870003,78.455704,1604200,0.0064437843310753,3.889999000000003,-0.0054950774011466,"[""novartis ' russian growth plans get delayed URL $nvs pharma by AT_USER"", 'rt AT_USER round two today : novartis joins an atlas syndicate to back cancer drug upstart raze - - biotech $nvs URL', 'rt AT_USER from yesterday : indian pricing authority fines novartis over cost of pain drug voveran URL $nvs pharma h …']","[87.370003, 88.599998]","[87.839996, 88.800003]","[86.800003, 87.269997]","[86.870003, 87.349998]","[78.455704, 78.889206]","[1604200, 2072300]",0.971279198069094,0.0422254072768315,0.0126984456895694,0.0025596114639179,1.0390628881334407,-0.3070152017377033,0.2920923586744596,1.595324766809659,0.4238120375541986,0.0577413537586909,0.5195863336380739,0.4660134068739134,0.3667882829562192,1.0
105,531,531,2014-10-15,86.389999,86.550003,84.690002,86.220001,77.86866,2023800,0.0043219114660018,2.809998000000008,-0.0074824677973132,"['rt AT_USER $teva v sandoz today at scotus ; read my preview here URL $nvs patents generics copaxone ms phar …', 'notable two hundred day moving average cross - $nvs $pph stocks URL', '$nvs ctl 019 data published in nejm showing 27/30 crs ( 90 % ) in r / r all URL URL', ""novartis ' russian growth plans get delayed URL $nvs pharma by AT_USER"", 'rt AT_USER round two today : novartis joins an atlas syndicate to back cancer drug upstart raze - - biotech $nvs URL', 'rt AT_USER from yesterday : indian pricing authority fines novartis over cost of pain drug voveran URL $nvs pharma h …']","[86.389999, 87.370003]","[86.550003, 87.839996]","[84.690002, 86.800003]","[86.220001, 86.870003]","[77.86866, 78.455704]","[2023800, 1604200]",0.9108394566804398,0.0422254072768315,0.0122220160783499,0.0057153271509399,0.9244761883148132,0.490286197232953,0.2295233925336586,1.595324766809659,0.4066737631662311,0.1290149628510282,0.5136903221915617,0.4660134068739134,0.3788481137706836,1.0
106,532,532,2014-10-16,84.269997,85.629997,84.169998,85.019997,76.784882,3134300,0.0038493642802475,2.670005000000004,-0.0139179307130835,"['rt AT_USER $teva v sandoz today at scotus ; read my preview here URL $nvs patents generics copaxone ms phar …', 'notable two hundred day moving average cross - $nvs $pph stocks URL', '$nvs ctl 019 data published in nejm showing 27/30 crs ( 90 % ) in r / r all URL URL']","[84.269997, 86.389999]","[85.629997, 86.550003]","[84.169998, 84.690002]","[85.019997, 86.220001]","[76.784882, 77.86866]","[3134300, 2023800]",0.6448431625944515,0.030128143719086,0.0080270593415418,0.0102130658791095,-0.0844582629304863,1.626653898202309,-0.0458436546418437,0.6544787819562464,0.2557714726535888,0.2305989151789844,0.4877418790211016,0.3270287693672398,0.3252852590552286,1.0
107,534,534,2014-10-20,86.580002,87.989998,86.489998,87.900002,79.385933,1718300,0.0139807866260062,2.880004999999997,0.0146601067064564,"['rt AT_USER $nvs adcom on secukinumab : risk / ben merits ok in psoriasis ? 7 yes , zero no , zero abstain']","[86.580002, 86.489998]","[87.989998, 87.239998]","[86.489998, 86.050003]","[87.900002, 86.629997]","[79.385933, 78.238937]","[1718300, 1627600]",0.5469851499271341,0.0227891390971362,0.006226214519822,0.0032850193092505,-0.5175817719377072,-0.1237386498333177,-0.147149096070103,0.083699035080257,0.1909909217432779,0.0741250968865584,0.4781956442166001,0.2427114448605405,0.2465057769267442,1.0
108,535,535,2014-10-21,87.610001,88.68,87.489998,88.610001,80.027161,1319700,0.0126292393998848,3.5900039999999933,0.0080773490767382,"['rt AT_USER $nvs adcom on secukinumab : risk / ben merits ok in psoriasis ? 7 yes , zero no , zero abstain']","[87.610001, 86.580002]","[88.68, 87.989998]","[87.489998, 86.489998]","[88.610001, 87.900002]","[80.027161, 79.385933]","[1319700, 1718300]",1.1584575456587871,0.0470521671332937,0.0097879726155339,0.0024831424626375,0.339061258068821,-0.3263353331264366,0.4858647909110585,1.97071855806888,0.3191155934899129,0.0560142584670095,0.5378459365842778,0.5214677222882983,0.3586108777073746,1.0
109,547,547,2014-11-06,92.139999,92.599998,91.93,92.029999,83.115891,815100,0.0072213314271487,0.9900050000000108,-0.0064773617557172,"[""rt AT_USER fda advisers spurn novartis ' blood cancer drug , putting approval in doubt . URL by AT_USER $nvs""]","[92.139999, 92.900002]","[92.599998, 92.93]","[91.93, 92.339996]","[92.029999, 92.629997]","[83.115891, 83.657776]","[815100, 828500]",2.517732198337922,0.0285526911823738,0.0079669312593634,0.0028553126281729,-0.0989197454685052,-0.2323053814242488,1.893025175212356,0.5319503947373244,0.2536085265508939,0.0644199304365375,0.6704457579437798,0.308928502420198,0.3243506793378523,1.0
110,548,548,2014-11-07,91.68,91.870003,91.190002,91.760002,82.872055,1097100,0.0053519154704837,0.9300000000000068,-0.0029337933601412,"[""AT_USER AT_USER wow . that's a lot of variation for $nvs : 2cr vs . 4pds in 6pts"", ""rt AT_USER fda advisers spurn novartis ' blood cancer drug , putting approval in doubt . URL by AT_USER $nvs""]","[91.68, 92.139999]","[91.870003, 92.599998]","[91.190002, 91.93]","[91.760002, 92.029999]","[82.872055, 83.115891]","[1097100, 815100]",2.702753884641836,0.0188923680954021,0.0083125119534333,0.0028949454389304,-0.0158036873520916,-0.2222920283227487,2.084564969388852,-0.2193663096875144,0.2660398629302473,0.0653150597008047,0.6884949744896607,0.1979417080901312,0.304447901302711,1.0
111,549,549,2014-11-10,92.309998,92.639999,91.889999,92.629997,83.657776,833400,0.0067651021304005,0.869995000000003,0.0094812007523714,"[""AT_USER AT_USER wow . that's a lot of variation for $nvs : 2cr vs . 4pds in 6pts""]","[92.309998, 91.68]","[92.639999, 91.870003]","[91.889999, 91.190002]","[92.629997, 91.760002]","[83.657776, 82.872055]","[833400, 1097100]",5.895977533189606,0.0185624101635048,0.0079805854558181,0.0009797458862189,-0.0956357570816071,-0.7061731615200971,5.390282329448502,-0.245028278108244,0.254099699559198,0.0220592034095827,1.0,0.194150843872096,0.3675774367102192,1.0
112,562,562,2014-11-28,96.510002,96.970001,96.43,96.650002,87.288406,445700,0.0048850691233261,1.880004999999997,0.0114064883090516,"['URL ddt : $nvs novartis says lcz 696 granted accelerated assessment in e URL URL', '$nvs nvs up +1.32 % percent today $nvs stock high is at 96.87 and the low 96.43 with current volume of 160,337 . nova URL']","[96.510002, 95.099998]","[96.970001, 95.739998]","[96.43, 95.07]","[96.650002, 95.559998]","[87.288406, 86.303978]","[445700, 802600]",-0.1466175794191861,0.0076311412238703,0.0021773942391937,0.0045725771029203,-1.4913687557660038,0.201566837720684,-0.8651866768163317,-1.0951908328145112,0.0453454973554843,0.1032053119538462,0.410533381976582,0.0685622391590645,0.1569116076112442,0.0
113,563,563,2014-12-01,96.849998,96.900002,96.230003,96.389999,87.053589,891000,0.0050482744492056,1.880004999999997,-0.0026901499701986,"[""rt AT_USER novartis ' gilenya fails in primary progressive multiple sclerosis study URL $nvs pharma"", 'URL ddt : $nvs novartis says lcz 696 granted accelerated assessment in e URL URL', '$nvs nvs up +1.32 % percent today $nvs stock high is at 96.87 and the low 96.43 with current volume of 160,337 . nova URL']","[96.849998, 96.510002]","[96.900002, 96.970001]","[96.230003, 96.43]","[96.389999, 96.650002]","[87.053589, 87.288406]","[891000, 445700]",-0.2832579182211054,0.0033451702552719,0.002146020473542,0.0029187099045204,-1.4989145005775182,-0.2162878620606806,-1.0066407025208457,-1.4285256037530392,0.0442169104841806,0.0658517934876017,0.3972038576748343,0.0193210104637222,0.1316483930275847,0.0
114,564,564,2014-12-02,95.110001,96.099998,94.900002,95.980003,86.683296,2608200,0.0063170748889907,1.610000999999997,-0.0042535118192086,"[""rt AT_USER novartis ' gilenya fails in primary progressive multiple sclerosis study URL $nvs pharma""]","[95.110001, 96.849998]","[96.099998, 96.900002]","[94.900002, 96.230003]","[95.980003, 96.389999]","[86.683296, 87.053589]","[2608200, 891000]",-0.2276808712077263,0.0157940010936612,0.0059596676512625,0.0022084491980693,-0.5816893028215316,-0.3957374421404847,-0.9491057380605474,-0.4603370167631483,0.1814026147551096,0.0498101569886511,0.4026255040589093,0.1623447805251462,0.1990457640819541,0.0
115,566,566,2014-12-04,95.790001,96.199997,95.389999,95.769997,86.493637,1330700,0.0020605591620679,0.989998,0.0011498326928776,['$teva copaxone 40mg approved in eu . let the switch begin ! the barriers for generics in uncooperative ms market cont to grow . + $nvs $rcpt'],"[95.790001, 95.550003]","[96.199997, 95.839996]","[95.389999, 95.040001]","[95.769997, 95.660004]","[86.493637, 86.394295]","[1330700, 1651100]",-0.0758052108575912,0.0168718594412533,0.0060233836822319,9.78069788778235e-05,-0.5663648780956275,-0.9289977738644568,-0.7918796674036133,-0.3765082488990748,0.1836946276694008,0.0021401184350836,0.4174412628840967,0.1747282217065789,0.19450105767379,0.0
116,567,567,2014-12-05,95.400002,96.050003,95.290001,95.830002,86.547821,737800,0.002374233848602,0.7299950000000024,0.0006265532200027,"['cancer ’ s super-survivors : how immunotherapy is transforming oncology URL $bmy $nvs', '$teva copaxone 40mg approved in eu . let the switch begin ! the barriers for generics in uncooperative ms market cont to grow . + $nvs $rcpt']","[95.400002, 95.790001]","[96.050003, 96.199997]","[95.290001, 95.389999]","[95.830002, 95.769997]","[86.547821, 86.493637]","[737800, 1330700]",-0.0031518302145774,0.02405902557931,0.0060588091522994,0.0018382400367959,-0.5578446526332177,-0.4892719400069832,-0.7166667891049514,0.1824624944584628,0.184968963714101,0.0414487754004693,0.4245287380131585,0.2573010842080727,0.2270618903339504,1.0
117,568,568,2014-12-08,95.690002,96.029999,95.589996,95.769997,86.493637,656300,0.0017362753465105,0.3199989999999957,-0.0006261608968763,"['rt AT_USER impressive rt AT_USER $nvs upenn car-t r / r all response slide ash 14 URL', 'cancer ’ s super-survivors : how immunotherapy is transforming oncology URL $bmy $nvs']","[95.690002, 95.400002]","[96.029999, 96.050003]","[95.589996, 95.290001]","[95.769997, 95.830002]","[86.493637, 86.547821]","[656300, 737800]",-0.0242288192344433,0.0294630841277071,0.0080310900684357,0.0013762678734547,-0.0834888276104189,-0.6059906462048243,-0.7384862969657441,0.6027547996481598,0.2559164672170329,0.0310148749331575,0.4224726377442969,0.3193879449951072,0.2571979812223987,1.0
118,569,569,2014-12-09,95.010002,95.169998,93.68,94.339996,85.202148,1503100,0.0067112896365344,1.490005999999994,-0.0149316178844612,"['rt AT_USER $juno files for $150m ipo URL $nvs $kite ht AT_USER cc AT_USER AT_USER AT_USER URL', ""AT_USER AT_USER AT_USER thnx . now waiting for their ph2 dlbcl protocol . i guess $nvs results in dlbcl are poorer to $kite's"", 'rt AT_USER impressive rt AT_USER $nvs upenn car-t r / r all response slide ash 14 URL']","[95.010002, 95.690002]","[95.169998, 96.029999]","[93.68, 95.589996]","[94.339996, 95.769997]","[85.202148, 86.493637]","[1503100, 656300]",0.1478305619554934,0.0294630841277071,0.0079670492643674,0.00386372525189,-0.0988913639329081,0.0224732093517929,-0.5603654554708595,0.6027547996481598,0.2536127714636576,0.0871954952449174,0.4392573568325573,0.3193879449951072,0.2748633921340599,1.0
119,570,570,2014-12-10,95.010002,95.029999,94.059998,94.239998,85.111832,1449800,0.0063913431808074,1.590003999999993,-0.0010599746050444,"['rt AT_USER $juno files for $150m ipo URL $nvs $kite ht AT_USER cc AT_USER AT_USER AT_USER URL', ""AT_USER AT_USER AT_USER thnx . now waiting for their ph2 dlbcl protocol . i guess $nvs results in dlbcl are poorer to $kite's""]","[95.010002, 95.010002]","[95.029999, 95.169998]","[94.059998, 93.68]","[94.239998, 94.339996]","[85.111832, 85.202148]","[1449800, 1503100]",0.4847028718436857,0.0294630841277071,0.0094271394226815,0.0042608792727755,0.2522768018127517,0.1228154099375654,-0.2116255094206532,0.6027547996481598,0.3061355894730305,0.0961654416030304,0.4721198898196132,0.3193879449951072,0.2984522164726954,1.0
120,573,573,2014-12-15,93.099998,93.370003,91.550003,91.639999,82.763672,1195900,0.0083675127428979,2.699996999999996,-0.0201026310982452,"['rt AT_USER pharmalot .. pharmalittle .. good morning .. sunshines & headlines for a new week .. URL pharma $teva $nvs', 'rt AT_USER pharmalot .. pharmalittle .. good morning .. sunshines & headlines for a new week .. URL pharma $teva $nvs']","[93.099998, 94.690002]","[93.370003, 94.769997]","[91.550003, 93.519997]","[91.639999, 93.519997]","[82.763672, 84.461578]","[1195900, 1606000]",0.5863870466856699,0.0398254328461444,0.0089466294069813,0.0092394166512573,0.1367087186536312,1.3806583876860137,-0.106359114387108,1.4086704630421691,0.2888505335039913,0.2086085011678662,0.4820393740037403,0.438440264015439,0.3544846681727592,1.0
121,574,574,2014-12-16,91.190002,92.830002,91.110001,91.650002,82.772705,1371300,0.0085963441142222,2.699996999999996,0.0001091553918501,"['trending biotech topics include $nbix , $avxl , $nvs stocks invest see more URL', 'rt AT_USER pharmalot .. pharmalittle .. good morning .. sunshines & headlines for a new week .. URL pharma $teva $nvs', 'rt AT_USER pharmalot .. pharmalittle .. good morning .. sunshines & headlines for a new week .. URL pharma $teva $nvs']","[91.190002, 93.099998]","[92.830002, 93.370003]","[91.110001, 91.550003]","[91.650002, 91.639999]","[82.772705, 82.763672]","[1371300, 1195900]",1.222735251083591,0.0326146057794494,0.0149073783673497,0.0047247429154547,1.5703361333468937,0.2400120042824643,0.5524069282850596,0.8478595275121633,0.5032724519466726,0.1066420621922776,0.5441163487043952,0.3555955627155123,0.3774066063897144,1.0
122,575,575,2014-12-17,91.690002,92.68,91.480003,92.290001,83.350716,2071000,0.0102026593641772,2.699996999999996,0.0069830767706913,"['trending biotech topics include $nbix , $avxl , $nvs stocks invest see more URL']","[91.690002, 91.190002]","[92.68, 92.830002]","[91.480003, 91.110001]","[92.290001, 91.650002]","[83.350716, 82.772705]","[2071000, 1371300]",1.202930596404944,0.021983946380697,0.0149117519780643,0.0036864046060791,1.5713880360965875,-0.0223274041993051,0.5319045776867969,0.0210764154540202,0.503429780833727,0.0831906089855176,0.5421843670645559,0.2334606405540026,0.3405663493594508,1.0
123,577,577,2014-12-19,94.410004,95.0,94.0,94.610001,85.445992,1593000,0.0098725250883416,2.970001999999994,0.0004229776884847,['rt AT_USER $juno prices upsized ipo : 11m shares at $24 -> ~ $2b mkt cap $nvs $kite $blcm $alcls $blue URL'],"[94.410004, 93.690002]","[95.0, 94.57]","[94.0, 93.43]","[94.610001, 94.57]","[85.445992, 85.409866]","[1593000, 1275300]",0.7656188648364997,0.021983946380697,0.0106287338987316,0.0035997889932834,0.541273837866916,-0.0442111085959714,0.0791868410318642,0.0210764154540202,0.3493597202756917,0.0812343467806928,0.4995237779260055,0.2334606405540026,0.2908946213840981,1.0
124,578,578,2014-12-22,95.269997,95.540001,95.029999,95.300003,86.06916,1236600,0.0088840638347552,3.650001000000003,0.0072931190435143,"['rt AT_USER biosimilar pricing : sandoz vows not to make omnitrope ‘ mistake ’ with filgrastim URL $nvs fdacms 14', 'rt AT_USER $juno prices upsized ipo : 11m shares at $24 -> ~ $2b mkt cap $nvs $kite $blcm $alcls $blue URL']","[95.269997, 94.410004]","[95.540001, 95.0]","[95.029999, 94.0]","[95.300003, 94.610001]","[86.06916, 85.445992]","[1236600, 1593000]",0.0945621606021882,0.0095483210980401,0.009752738514617,0.002552128940479,0.3305870590474593,-0.3089056845940013,-0.6155104432565816,-0.9460851298392684,0.3178481414359116,0.0575723567692594,0.4340609232128818,0.090588588223434,0.2250175024103717,1.0
125,579,579,2014-12-23,94.68,94.830002,92.849998,93.25,84.21772,1974400,0.0165428992361572,3.010002,-0.0215110486407854,['rt AT_USER biosimilar pricing : sandoz vows not to make omnitrope ‘ mistake ’ with filgrastim URL $nvs fdacms 14'],"[94.68, 95.269997]","[94.830002, 95.540001]","[92.849998, 95.029999]","[93.25, 95.300003]","[84.21772, 86.06916]","[1974400, 1236600]",0.7197519152820062,0.0155406209565887,0.0052075513456483,0.0096671748413993,-0.7625817648150479,1.4887328269721518,0.0317040499457386,-0.4800432654919059,0.1543472527168715,0.2182696598570375,0.4950493699722902,0.1594337133789019,0.2567749989812753,1.0
126,585,585,2015-01-02,92.830002,93.050003,92.010002,92.25,83.31459,723900,0.0016538973990078,1.849998,-0.004424821738622,"['$gpw . v - 3 p / e , insider buying and a stock repurchase program underway . 740 % upside $adsk $rio $nvs investors read URL']","[92.830002, 93.290001]","[93.050003, 93.82]","[92.010002, 92.529999]","[92.25, 92.660004]","[83.31459, 83.684875]","[723900, 922500]",0.7336184274780813,0.0485437449229571,0.0143772261131272,0.0025010328369895,1.4428285314216762,-0.3218152743145418,0.046059063917557,2.0867237164092405,0.4842016499093938,0.0564183226079345,0.4964020745463473,0.53860435797618,0.3939066012599639,1.0
127,586,586,2015-01-05,93.43,93.449997,92.18,92.449997,83.495216,1378000,0.0035494758933789,1.610000999999997,0.0021679891598915,"[""rt AT_USER fda staff back approval of novartis ' biosimilar version of amgen's neupogen URL $nvs $amgn"", 'out with the old : AT_USER completes animal health sale to AT_USER as part of overhaul . URL $nvs $lly $gsk', '$gpw . v - 3 p / e , insider buying and a stock repurchase program underway . 740 % upside $adsk $rio $nvs investors read URL']","[93.43, 92.830002]","[93.449997, 93.050003]","[92.18, 92.010002]","[92.449997, 92.25]","[83.495216, 83.31459]","[1378000, 723900]",1.0485073740636974,0.0485437449229571,0.0155245330137172,0.0055454057011936,1.718768792735906,0.4473550136174555,0.3720411972680879,2.0867237164092405,0.5254729311364144,0.1251771915855661,0.5271200887335734,0.53860435797618,0.4290936423579334,2.0
128,587,587,2015-01-06,92.379997,92.730003,90.980003,91.669998,82.790764,1180100,0.0039300111442798,1.5400009999999895,-0.0084369824262946,"[""rt AT_USER fda staff back approval of novartis ' biosimilar version of amgen's neupogen URL $nvs $amgn"", 'out with the old : AT_USER completes animal health sale to AT_USER as part of overhaul . URL $nvs $lly $gsk']","[92.379997, 93.43]","[92.730003, 93.449997]","[90.980003, 92.18]","[91.669998, 92.449997]","[82.790764, 83.495216]","[1180100, 1378000]",0.9059939284852632,0.0465949929401542,0.0135929414266312,0.008434417593416,1.2541992106835511,1.177272867999793,0.2245071617786539,1.9351625414589504,0.4559891168532633,0.1904271458562207,0.5132176317225632,0.5162152791049622,0.4189622933842524,2.0
129,588,588,2015-01-07,91.349998,92.300003,91.25,92.07,83.152023,1432300,0.0051210460696618,0.990005999999994,0.0043634996043087,"['rt AT_USER $nvs is the forerunner in car-t as expected with focus on using crispr ex vivo for engineering car t-cells and hscs http …', '$nvs sandoz sigrid balser : we have quite some extensive postmarketing experience w / zarzio ( european name for zarxio ) fda odac $amgn', 'pfizer complains , advertising watchdog acts against novartis theraflu promo URL $pfe $nvs pharma marketing', 'rt AT_USER novartis clears an fda hurdle with its pioneering biosimilar . URL by AT_USER $nvs $amgn', ""fda's christl : biosimilars app from $nvs sandoz requests biosimilar but not interchangeable odac zarxio $amgn pharma biotech""]","[91.349998, 92.379997]","[92.300003, 92.730003]","[91.25, 90.980003]","[92.07, 91.669998]","[83.152023, 82.790764]","[1432300, 1180100]",1.2760608429805358,0.0161645958695683,0.0135675140490288,0.0018437265143587,1.2480836393255004,-0.4878857643593381,0.6076111213735569,-0.4315145805770241,0.4550744353052358,0.0415726905740425,0.5493183613701119,0.1666025186777003,0.3031420014817726,1.0
130,589,589,2015-01-08,94.169998,95.669998,94.0,95.269997,86.042061,1932600,0.0158376283944165,3.599998999999997,0.0347561312045183,"['rt AT_USER $nvs is the forerunner in car-t as expected with focus on using crispr ex vivo for engineering car t-cells and hscs http …', '$nvs sandoz sigrid balser : we have quite some extensive postmarketing experience w / zarzio ( european name for zarxio ) fda odac $amgn', 'pfizer complains , advertising watchdog acts against novartis theraflu promo URL $pfe $nvs pharma marketing', 'rt AT_USER novartis clears an fda hurdle with its pioneering biosimilar . URL by AT_USER $nvs $amgn', ""fda's christl : biosimilars app from $nvs sandoz requests biosimilar but not interchangeable odac zarxio $amgn pharma biotech""]","[94.169998, 91.349998]","[95.669998, 92.300003]","[94.0, 91.25]","[95.269997, 92.07]","[86.042061, 83.152023]","[1932600, 1432300]",-1.934375486872202,0.0534143154561903,0.0151006978348698,0.0053078720392555,1.6168316476309894,0.3873413939670139,-2.7159253035764865,2.46552481537379,0.5102266000534929,0.1198123605784914,0.2361342061403608,0.594562011273622,0.3651837945114917,1.0
131,591,591,2015-01-12,96.0,96.099998,95.190002,95.480003,86.231728,1265400,0.0149601413349921,4.45000499999999,-0.0066583435291819,"['rt AT_USER $nvs : re : io : important to own own set of checkpoint inh , even if late , cause won ’ t have to share economics w / combo therap …']","[96.0, 96.459999]","[96.099998, 96.809998]","[95.190002, 95.730003]","[95.480003, 96.120003]","[86.231728, 86.809738]","[1265400, 1977500]",-1.0441762678761883,0.0531341007354285,0.0134279723678755,0.005733417959013,1.2145222897494916,0.4948568962488722,-1.7943653578818015,2.4437315483537656,0.450054798481987,0.129423553899984,0.3229748289538459,0.5913426434221069,0.3734489561894809,1.0
132,592,592,2015-01-13,96.610001,97.120003,95.669998,96.360001,87.026489,1727600,0.0146328350728154,4.290001000000004,0.0092165686253695,"['rt AT_USER $nvs : re : io : important to own own set of checkpoint inh , even if late , cause won ’ t have to share economics w / combo therap …']","[96.610001, 96.0]","[97.120003, 96.099998]","[95.669998, 95.190002]","[96.360001, 95.480003]","[87.026489, 86.231728]","[1727600, 1265400]",-1.5031536384634854,0.0482388709480192,0.0208405645154652,0.0082001509894416,2.997334380542158,1.118084680721377,-2.269511989880153,2.0630126139903,0.7167028723208666,0.1851361031860182,0.2782007156221703,0.5351016816320879,0.4287853431902858,2.0
133,593,593,2015-01-14,96.470001,97.07,96.220001,96.809998,87.432899,2084900,0.006424996686505,1.5400009999999895,0.0046699563649859,"['trending biotech topics include $nvs , $ibdc , evista stocks invest see more URL']","[96.470001, 96.610001]","[97.07, 97.120003]","[96.220001, 95.669998]","[96.809998, 96.360001]","[87.432899, 87.026489]","[2084900, 1727600]",-1.874798928463511,0.0479141593520924,0.0230429451955941,0.0120487513113809,3.527031796356234,2.09044554116911,-2.654249929390345,2.03775867124492,0.7959275962128033,0.272058900454045,0.2419460124494359,0.5313710922108792,0.4603259003317909,2.0
134,594,594,2015-01-15,98.720001,100.82,97.43,100.580002,90.837738,11050800,0.0165506588691369,5.099998999999997,0.0389423001537505,"['rt AT_USER a few premarket movers are : up ... $tgt $nvs $gdx $jrjc $chk $hal $abx gold oil $slb down .. $bbry $bby $ehth $c $bac $…', 'rt AT_USER novartis ( $nvs ) goes 5 % up on pre market thanks to swiss franc surge of its value nasdaq biotech', 'popular : $tgt , $c , $bby , $nvs , $dis , $adbe , $glw', '$nvs : 3mrunaway + : 4 [ + 3 % , . 5 % offhi ] , fltbo + , alltfs + ; tlm : 1.9 ; ilm : 0.7 , gap + [ +1.7 % ] , 1yrhi + athi , dyvol : 6.95 m : 3.3 x : 3x , dyrng : 3.1 % : 3.7 x : 2.9 x', 'trending biotech topics include $nvs , $ibdc , evista stocks invest see more URL']","[98.720001, 96.470001]","[100.82, 97.07]","[97.43, 96.220001]","[100.580002, 96.809998]","[90.837738, 87.432899]","[11050800, 2084900]",-0.5047567230871332,0.0479141593520924,0.0131539732019246,0.0030663597194513,1.1486223972155134,-0.1789836763616016,-1.235942663506601,2.03775867124492,0.4401984151305808,0.069186547386763,0.3755962290041394,0.5313710922108792,0.3540880709330906,1.0
135,595,595,2015-01-16,99.540001,101.209999,98.879997,100.949997,91.171898,8590500,0.0141684721931517,5.469994,0.0036786139654283,"['nvs +0.04 % stock charts $nvs novartis ag ads ( nyse ) last updated : 01/16 / 2015 13:09 : 44 nvs stock chart - 1 mont URL', ""observar en gráfico 15 ' $nvs , la entrada de volumen y el breakout arriba de 101.8 , buscando el entero de u $d 101 URL"", 'rt AT_USER a few premarket movers are : up ... $tgt $nvs $gdx $jrjc $chk $hal $abx gold oil $slb down .. $bbry $bby $ehth $c $bac $…', 'rt AT_USER novartis ( $nvs ) goes 5 % up on pre market thanks to swiss franc surge of its value nasdaq biotech', 'popular : $tgt , $c , $bby , $nvs , $dis , $adbe , $glw', '$nvs : 3mrunaway + : 4 [ + 3 % , . 5 % offhi ] , fltbo + , alltfs + ; tlm : 1.9 ; ilm : 0.7 , gap + [ +1.7 % ] , 1yrhi + athi , dyvol : 6.95 m : 3.3 x : 3x , dyrng : 3.1 % : 3.7 x : 2.9 x']","[99.540001, 98.720001]","[101.209999, 100.82]","[98.879997, 97.43]","[100.949997, 100.580002]","[91.171898, 90.837738]","[8590500, 11050800]",-1.1542098755173165,0.0517152565388175,0.0121894900091774,0.008140667665302,0.9166533014984182,1.1030560335758277,-1.908275326929755,2.3333831328512105,0.4055037252737217,0.1837926389412277,0.3122408417585448,0.5750416390335426,0.3691447112517592,1.0
136,596,596,2015-01-20,102.529999,102.589996,100.68,101.480003,91.650566,2847400,0.0145949017693316,5.120002,0.0052501834150624,"['nvs +0.04 % stock charts $nvs novartis ag ads ( nyse ) last updated : 01/16 / 2015 13:09 : 44 nvs stock chart - 1 mont URL', ""observar en gráfico 15 ' $nvs , la entrada de volumen y el breakout arriba de 101.8 , buscando el entero de u $d 101 URL""]","[102.529999, 99.540001]","[102.589996, 101.209999]","[100.68, 98.879997]","[101.480003, 100.949997]","[91.650566, 91.171898]","[2847400, 8590500]",-1.609954858988941,0.025287615821072,0.0180667509066615,0.0111402734672337,2.330200894587657,1.860915783766932,-2.380075698415608,0.2780142025347712,0.6169223851108587,0.2515404187039033,0.2677820539229035,0.271416273860711,0.3519152828995942,1.0
137,598,598,2015-01-22,96.099998,97.110001,95.860001,96.839996,87.459984,3062400,0.0142044980483297,4.640006999999997,-0.0193418126582278,"['novartis eyes psoriasis dominance with new approvals for cosentyx URL $nvs pharma by AT_USER', 'big gaps : URL $cci , $ebay , $beav , $joy , $alk , $jci , $xlnx , $dfs , $sndk , $nvo , $chkp , $nvs , $ul , $emr , $cp']","[96.099998, 99.599998]","[97.110001, 99.889999]","[95.860001, 98.099998]","[96.839996, 98.75]","[87.459984, 89.184982]","[3062400, 6145100]",0.4868959331484209,0.0276713240267659,0.0162485350319523,0.0091075260094772,1.8928994512380788,1.347335806176256,-0.2093551890094802,0.463403425782148,0.5515169572711349,0.2056296770349345,0.4723338271108481,0.2988025351675443,0.3820707491461155,1.0
138,599,599,2015-01-23,98.010002,98.059998,96.709999,96.870003,87.487091,1882300,0.0134829420867287,4.640006999999997,0.0003098616402255,"['rt AT_USER icymi : novartis adds another cosentyx approval with fda nod URL $nvs cosentyx fda secukinumab p …', '$arry $nvs : array biopharma ( arry ) to acquire encorafenib rights from novartis : URL', 'novartis eyes psoriasis dominance with new approvals for cosentyx URL $nvs pharma by AT_USER', 'big gaps : URL $cci , $ebay , $beav , $joy , $alk , $jci , $xlnx , $dfs , $sndk , $nvo , $chkp , $nvs , $ul , $emr , $cp']","[98.010002, 96.099998]","[98.059998, 97.110001]","[96.709999, 95.860001]","[96.870003, 96.839996]","[87.487091, 87.459984]","[1882300, 3062400]",0.7744866131296634,0.0276713240267659,0.0186866391645679,0.0048452862431426,2.479291018410979,0.2704676515378219,0.0883669902176822,0.463403425782148,0.6392211986264286,0.1093646008707935,0.500388843597036,0.2988025351675443,0.3869442945654506,1.0
139,600,600,2015-01-26,98.019997,98.019997,96.050003,96.489998,87.143898,4615600,0.011237049427123,4.9900049999999965,-0.003922834605466,"[""rt AT_USER icymi : novartis meningitis b vaccine bexsero ok'd in us URL $nvs bexsero pharma vaccines mening …"", 'rt AT_USER icymi : novartis adds another cosentyx approval with fda nod URL $nvs cosentyx fda secukinumab p …', '$arry $nvs : array biopharma ( arry ) to acquire encorafenib rights from novartis : URL']","[98.019997, 98.010002]","[98.019997, 98.059998]","[96.050003, 96.709999]","[96.489998, 96.870003]","[87.143898, 87.487091]","[4615600, 1882300]",0.5756561359137089,0.0211101120264637,0.018505675661736,0.0052225927689673,2.4357672531184544,0.3657953206678244,-0.1174680631900693,-0.0468847015112277,0.632711523130394,0.1178862804188631,0.4809925532978717,0.2234212171435542,0.3637528934976708,1.0
140,601,601,2015-01-27,98.480003,99.540001,98.010002,98.93,89.347557,3132400,0.0159675270899831,2.440002000000007,0.0252876158210719,"['learn the secrets of pennystock trading in this video URL $ung $rexx $emes $srpt $nvs $has URL', ""rt AT_USER icymi : novartis meningitis b vaccine bexsero ok'd in us URL $nvs bexsero pharma vaccines mening …""]","[98.480003, 98.019997]","[99.540001, 98.019997]","[98.010002, 96.050003]","[98.93, 96.489998]","[89.347557, 87.143898]","[3132400, 4615600]",0.8902957771539611,0.0211101120264637,0.014609434507308,0.0044024415774032,1.498677271577128,0.1585815671948078,0.2082559820655357,-0.0468847015112277,0.4925547226003908,0.0993627056670078,0.5116862472756434,0.2234212171435542,0.3317562231716491,1.0
141,602,602,2015-01-28,98.43,99.07,97.029999,97.110001,87.703842,1985000,0.0156687844899022,2.440002000000007,-0.0183968361467705,"['rt AT_USER $nvs will present data fm phase - 2 trials of rth 258 vs lucentis / eylea at themaculasociety annual mtng feb 25-28 . ( source : n …', 'learn the secrets of pennystock trading in this video URL $ung $rexx $emes $srpt $nvs $has URL']","[98.43, 98.480003]","[99.07, 99.540001]","[97.029999, 98.010002]","[97.110001, 98.93]","[87.703842, 89.347557]","[1985000, 3132400]",0.6157738346336584,0.0180698353579089,0.0127004902697852,0.0058244897804003,1.0395546327562049,0.5178664756281295,-0.0759370626400476,-0.2833375226636484,0.4238855858306311,0.1314804620757046,0.4849061109244593,0.1884916854621072,0.3071909610732256,1.0
142,603,603,2015-01-29,98.209999,99.209999,97.93,99.160004,89.555275,1935400,0.0179151773778538,2.6700060000000008,0.0211101120264636,"[""novartis ' bexsero picks up fda nod--but with competition looming , approval isn't everything URL $nvs pharma vaccines"", 'rt AT_USER $kite ph1 / 2 multi-center study of anti-cd 19 car-t in refractory aggressive nhl posted URL ( n = 124 ) $nvs …', 'rt AT_USER $nvs will present data fm phase - 2 trials of rth 258 vs lucentis / eylea at themaculasociety annual mtng feb 25-28 . ( source : n …']","[98.209999, 98.43]","[99.209999, 99.07]","[97.93, 97.029999]","[99.160004, 97.110001]","[89.555275, 87.703842]","[1935400, 1985000]",0.3686435695026807,0.0077002051806939,0.0084996888143135,0.0067297049288056,0.0292144606924283,0.7465719027872092,-0.3317734516794281,-1.0898194902653966,0.2727730472775262,0.1519252540122007,0.4607980846736164,0.0693557102575559,0.2387130240552248,1.0
143,604,604,2015-01-30,97.900002,98.519997,97.389999,97.400002,87.965759,1483700,0.0206369248929134,2.6700060000000008,-0.0177491118294025,"[""novartis ' bexsero picks up fda nod--but with competition looming , approval isn't everything URL $nvs pharma vaccines"", 'rt AT_USER $kite ph1 / 2 multi-center study of anti-cd 19 car-t in refractory aggressive nhl posted URL ( n = 124 ) $nvs …']","[97.900002, 98.209999]","[98.519997, 99.209999]","[97.389999, 97.93]","[97.400002, 99.160004]","[87.965759, 89.555275]","[1483700, 1935400]",-0.5715836267533086,0.0137562462270302,0.0053249122459864,0.0055149244096995,-0.734355143419574,0.4396538203665475,-1.3051238045359108,-0.6188202535078536,0.1585689955830733,0.1244887545177039,0.3690771377589095,0.1389331535804035,0.1977670103600226,0.0
144,609,609,2015-02-06,99.419998,99.739998,98.300003,98.75,89.184982,2623800,0.0059350271720725,1.3399959999999993,0.0098169443724618,"['gsk is planning to partially spin off its hiv drug business , viiv URL $gsk $nvs $pfe URL']","[99.419998, 97.449997]","[99.739998, 97.790001]","[98.300003, 96.82]","[98.75, 97.790001]","[89.184982, 88.317978]","[2623800, 2445000]",-1.982341561304653,0.0025440509553048,0.015316684270215,0.0059311915474928,1.6687788235599714,0.5448250094800093,-2.765581169371348,-1.4908314197059396,0.5179961313879331,0.1338903813433017,0.2314550245720711,0.0101170053617388,0.2233646356662612,1.0
145,610,610,2015-02-09,102.260002,103.5,102.139999,102.459999,92.535637,4349700,0.0148976741070131,5.049994999999996,0.0375696101265823,"['gsk is planning to partially spin off its hiv drug business , viiv URL $gsk $nvs $pfe URL']","[102.260002, 99.419998]","[103.5, 99.739998]","[102.139999, 98.300003]","[102.459999, 98.75]","[92.535637, 89.184982]","[4349700, 2623800]",-0.0729011968009978,0.0016634638453071,0.0011297016709834,0.0127401854542108,-1.7433506456162764,2.265138531301752,-0.7888733481672191,-1.5593177218188292,0.0076575739238107,0.28767532845224,0.4177245549651862,0.0,0.1782643643353092,0.0
146,614,614,2015-02-13,101.989998,102.519997,101.730003,102.199997,92.300827,1526400,0.0011594189615754,0.260002,-0.001660701328689,"['$nvs : novartis ag announces that the fda has granted priority review designation to lcz 696 , an investigational ... URL']","[101.989998, 100.449997]","[102.519997, 102.370003]","[101.730003, 100.379997]","[102.199997, 102.370003]","[92.300827, 92.454361]","[1526400, 1823500]",0.3087184636154956,0.0081237351105751,0.0017987206780046,0.0146230967722107,-1.5824440220034648,2.740861941415324,-0.3938096522834076,-1.0568801042553395,0.0317237340513188,0.3302019368493693,0.4549522768967052,0.0742216167906145,0.222774891147002,1.0
147,615,615,2015-02-17,102.120003,102.300003,101.489998,102.25,92.345978,1534100,0.0009715274089363,0.1700060000000007,0.0004892661591762,"['update on prospects for drugs to make you live longer : novartis ... stocks biotech $nvs URL', '$nvs : novartis ag announces that the fda has granted priority review designation to lcz 696 , an investigational ... URL']","[102.120003, 101.989998]","[102.300003, 102.519997]","[101.489998, 101.730003]","[102.25, 102.199997]","[92.345978, 92.300827]","[1534100, 1526400]",0.1154459772740123,0.0081237351105751,0.0027058568964509,0.0001797031537613,-1.3642675209844697,-0.9083064501582456,-0.5938909129904355,-1.0568801042553395,0.0643555206843988,0.0039897894871393,0.4360981791526805,0.0742216167906145,0.1446662765287082,0.0
148,616,616,2015-02-18,102.190002,102.360001,101.410004,102.169998,92.273727,1219900,0.0010122538369988,0.2000049999999902,-0.0007824156479216,['update on prospects for drugs to make you live longer : novartis ... stocks biotech $nvs URL'],"[102.190002, 102.120003]","[102.360001, 102.300003]","[101.410004, 101.489998]","[102.169998, 102.25]","[92.273727, 92.345978]","[1219900, 1534100]",0.0908997746522323,0.0073349633251833,0.0026395687083559,0.0005919780957806,-1.380210578535657,-0.8041439017435212,-0.619301850983226,-1.1182256113370943,0.0619709813327296,0.0133012503316297,0.4337036505147141,0.0651594714430429,0.1435338384055291,0.0
149,618,618,2015-02-20,101.32,102.82,101.120003,102.599998,92.662079,1088100,0.0015269694516464,0.4299999999999926,0.0034229633251834,['jefferies analyst jeffrey holford price target revisions : merck $mrk to $63 from $69 ; novartis $nvs to chf 109 from chf 102 .'],"[101.32, 102.300003]","[102.82, 102.699997]","[101.120003, 102.0]","[102.599998, 102.25]","[92.662079, 92.345978]","[1088100, 931000]",0.0298196166854566,0.0058593553543094,0.0038015177786594,0.0002419573936001,-1.100748710112751,-0.8925777225293728,-0.6825337948646962,-1.232988741691934,0.1037689752498846,0.0053958364174312,0.4277451652159254,0.0482063119161053,0.1462790721998366,0.0
150,619,619,2015-02-23,103.279999,103.400002,102.480003,103.0,93.023331,1350100,0.0019163798515507,0.8300019999999932,0.0038986550467574,['jefferies analyst jeffrey holford price target revisions : merck $mrk to $63 from $69 ; novartis $nvs to chf 109 from chf 102 .'],"[103.279999, 101.32]","[103.400002, 102.82]","[102.480003, 101.120003]","[103.0, 102.599998]","[93.023331, 92.662079]","[1350100, 1088100]",-2.142024052020729,0.0292795043469572,0.0090809167245391,0.0010495769148211,0.1690063344694436,-0.6885301346070374,-2.9308890963302887,0.5884771658019314,0.2936811587231895,0.0236363763645411,0.2158776946325638,0.3172788093910687,0.2126185097778408,1.0
151,621,621,2015-02-25,102.629997,102.970001,102.050003,102.639999,92.698196,999200,0.0029491326690966,0.75,-9.744763570485038e-05,"['AT_USER your tweet about $nvs had a sentiment of 5 and was featured on market parse . URL', 'AT_USER your tweet about $nvs had a sentiment of 5 and was featured on market parse . URL', 'rt AT_USER $300b proposed pharma deals did not happen in 2014 . $30b down $270b to go . $pcyc $jnj $nvs $vrx $slxp URL']","[102.629997, 102.220001]","[102.970001, 102.989998]","[102.050003, 102.050003]","[102.639999, 102.650002]","[92.698196, 92.70723]","[999200, 1655400]",-1.693976157659789,0.0399838344105024,0.0091184003108402,0.0006152834596006,0.1780215601197041,-0.7982557289738313,-2.467056973829028,1.4209899000048618,0.2950295299661711,0.0138276150474033,0.2595856168215507,0.4402601288053312,0.252175722660114,1.0
152,622,622,2015-02-26,102.279999,103.0,102.120003,103.0,93.023331,908700,0.0029668930385756,0.4000020000000006,0.003507414297617,"['AT_USER your tweet about $nvs had a sentiment of 5 and was featured on market parse . URL', 'AT_USER your tweet about $nvs had a sentiment of 5 and was featured on market parse . URL', 'rt AT_USER $300b proposed pharma deals did not happen in 2014 . $30b down $270b to go . $pcyc $jnj $nvs $vrx $slxp URL']","[102.279999, 102.629997]","[103.0, 102.970001]","[102.120003, 102.050003]","[103.0, 102.639999]","[93.023331, 92.698196]","[908700, 999200]",-1.3523733390657116,0.0348661455745168,0.008220407311884,0.0013507678494519,-0.0379558933959123,-0.6124333067064756,-2.1134198685215706,1.0229695568022608,0.2627266460728047,0.0304389425859897,0.2929096199081951,0.3814633501498808,0.2418846396792176,1.0
153,623,623,2015-02-27,102.919998,103.260002,102.379997,102.400002,92.481453,850000,0.0035161568505438,0.5999979999999994,-0.0058252233009709,"[""from AT_USER novartis ' japan hit with 15 - day sales ban . URL $nvs""]","[102.919998, 102.279999]","[103.260002, 103.0]","[102.379997, 102.120003]","[102.400002, 103.0]","[92.481453, 93.023331]","[850000, 908700]",-0.151940945657073,0.0267802280605399,0.0085640608581806,0.0005810388951521,0.0446966639258299,-0.8069077248599676,-0.8706975793159237,0.3940998136106158,0.2750886584921289,0.0130541823487361,0.4100140774999012,0.2885647942719775,0.2466804281531859,1.0
154,624,624,2015-03-02,99.82,100.449997,99.620003,100.07,92.933716,1021800,0.0101757185030905,2.930000000000007,-0.0227539253368375,"[""view today's pharma news covering $nvs , $gsk , $amgn , kyprolis , $jnj , takeda , velcade , gilead sciences , natco pharma …"", 'high call volu $ivr 10255 % $cst 6645 % $wpg 5392 % $kbr 3724 % $voya 2384 % $bpop 1934 % $nvs 1932 % $yum 1861 % URL', ""from AT_USER novartis ' japan hit with 15 - day sales ban . URL $nvs""]","[99.82, 102.919998]","[100.449997, 103.260002]","[99.620003, 102.379997]","[100.07, 102.400002]","[92.933716, 92.481453]","[1021800, 850000]",1.0648240911481273,0.0164169814941204,0.0073801007964119,0.0048329996372613,-0.2400590964222174,0.2673634022868364,0.3889327341166615,-0.4118856785231765,0.2324988783333164,0.1090871009843948,0.5287118154433332,0.1695021599372983,0.2599499886745857,1.0
155,625,625,2015-03-03,100.0,100.309998,98.889999,99.059998,91.995743,1270200,0.0095390119035444,3.940002000000007,-0.0100929549315479,"[""view today's pharma news covering $nvs , $gsk , $amgn , kyprolis , $jnj , takeda , velcade , gilead sciences , natco pharma …"", 'high call volu $ivr 10255 % $cst 6645 % $wpg 5392 % $kbr 3724 % $voya 2384 % $bpop 1934 % $nvs 1932 % $yum 1861 % URL']","[100.0, 99.82]","[100.309998, 100.449997]","[98.889999, 99.620003]","[99.059998, 100.07]","[91.995743, 92.933716]","[1270200, 1021800]",1.0829154969816863,0.0295218720225116,0.0091945789312069,0.0087816497550149,0.1963433782833837,1.265002155320878,0.4076614800217845,0.6073269373486224,0.2977698510284987,0.1982695790170617,0.5304766664077384,0.3200633551165932,0.336644862892473,1.0
156,627,627,2015-03-05,99.139999,99.5,98.480003,98.949997,91.893585,1498300,0.0092182085101057,3.4500050000000044,-0.000908764126527,['abbvie buys pharmacyclics : the story is likely far from over URL $jnj $nvs $rhhby $abbv $pcyc'],"[99.139999, 98.389999]","[99.5, 99.220001]","[98.480003, 97.690002]","[98.949997, 99.040001]","[91.893585, 91.977173]","[1498300, 1267900]",0.9665626426739896,0.0186070795823414,0.0108891615936475,0.0096154964329378,0.6039096384113051,1.4756761160864464,0.2872096442875827,-0.2415541830653828,0.358727906443361,0.2171024740112571,0.5191262247104261,0.1946640477842869,0.3224051632373328,1.0
157,628,628,2015-03-06,97.910004,98.510002,97.360001,97.459999,90.509842,1223500,0.006312139541868,2.610000999999997,-0.0150580904009527,"['rt AT_USER novartis gets bragging rights on first u . s . biosim . but will its neupogen copy sell ? URL $nvs pharma …', 'AT_USER $nvs your tweet has been featured on market parse , for iphone . URL', ""rt AT_USER novartis wins landmark approval for a biosimilar of amgen's neupogen . URL by AT_USER $nvs $amgn"", '$nvs wins approval for first u . s . biosimilar drug - $amgn seeking to block launch | AT_USER URL', '$amgn news : "" fda clears first biosimilar premarket $nvs $amgn … "" URL board view : URL', 'abbvie buys pharmacyclics : the story is likely far from over URL $jnj $nvs $rhhby $abbv $pcyc']","[97.910004, 99.139999]","[98.510002, 99.5]","[97.360001, 98.480003]","[97.459999, 98.949997]","[90.509842, 91.893585]","[1223500, 1498300]",0.8895861587192159,0.0186070795823414,0.0093397088439247,0.0104658361757988,0.231248760635104,1.690517101087608,0.2075213645639327,-0.2415541830653828,0.3029905094583827,0.2363078741293987,0.5116170226509547,0.1946640477842869,0.3113948635057557,1.0
158,629,629,2015-03-09,97.410004,98.169998,97.110001,97.989998,91.002045,1163900,0.0075993782722428,1.5999989999999968,0.005438118258138,"['rt AT_USER novartis gets bragging rights on first u . s . biosim . but will its neupogen copy sell ? URL $nvs pharma …', 'AT_USER $nvs your tweet has been featured on market parse , for iphone . URL', ""rt AT_USER novartis wins landmark approval for a biosimilar of amgen's neupogen . URL by AT_USER $nvs $amgn"", '$nvs wins approval for first u . s . biosimilar drug - $amgn seeking to block launch | AT_USER URL', '$amgn news : "" fda clears first biosimilar premarket $nvs $amgn … "" URL board view : URL']","[97.410004, 97.910004]","[98.169998, 98.510002]","[97.110001, 97.360001]","[97.989998, 97.459999]","[91.002045, 90.509842]","[1163900, 1223500]",0.8021836502112568,0.017463618008221,0.0098459131438814,0.0003287800100122,0.3529966092156428,-0.870641718024168,0.1170397630579055,-0.3304851405261323,0.321199848224755,0.0073567739150578,0.5030907421147256,0.18152689559914,0.2532935649634196,1.0
159,630,630,2015-03-10,96.5,96.720001,95.809998,96.199997,89.339691,2661600,0.0098579260731818,2.8400040000000075,-0.0182671806973605,"['rt AT_USER $bmy , $lly , $mrk , $nvs 8 healthcare names cowen & amp ; co are talking about - URL ~ via AT_USER']","[96.5, 97.410004]","[96.720001, 98.169998]","[95.809998, 97.110001]","[96.199997, 97.989998]","[89.339691, 91.002045]","[2661600, 1163900]",0.5540052125620248,0.017463618008221,0.0048404316968571,0.0007930610391777,-0.8508781846909654,-0.7533396696832687,-0.1398817244497599,-0.3304851405261323,0.1411411103486568,0.0178428214122445,0.4788804646459992,0.18152689559914,0.2048478230015101,1.0
160,631,631,2015-03-11,96.059998,96.540001,95.739998,96.199997,89.339691,2005900,0.0100113385441153,2.75,0.0,"['rt AT_USER $bmy , $lly , $mrk , $nvs 8 healthcare names cowen & amp ; co are talking about - URL ~ via AT_USER']","[96.059998, 96.5]","[96.540001, 96.720001]","[95.739998, 95.809998]","[96.199997, 96.199997]","[89.339691, 89.339691]","[2005900, 2661600]",0.9061028555635748,0.0346249068979296,0.0110351064413638,0.0003056654863605,0.6390110218298058,-0.8764816744308341,0.2246199262365769,1.0042075914061197,0.3639778799688725,0.0068347194315433,0.513228257765723,0.3786917754166351,0.3156831581456935,1.0
161,635,635,2015-03-17,97.559998,97.900002,97.050003,97.599998,90.639862,1155400,0.0051451486426032,1.6800000000000068,-0.0028606355596844,['new indication for novartis bone marrow disorder drug cleared in europe URL premarket $nvs $incy'],"[97.559998, 97.279999]","[97.900002, 98.300003]","[97.050003, 97.239998]","[97.599998, 97.879997]","[90.639862, 90.899895]","[1155400, 1343100]",1.7214411329581296,0.0249323913607972,0.0131489083214679,0.0010944505307397,1.147404236289236,-0.6771926757554972,1.068681662761071,0.2503871689022533,0.4400162196730252,0.0246498721533712,0.5927660536901813,0.2673351242181386,0.3311918174336791,1.0
162,636,636,2015-03-18,98.269997,100.510002,98.120003,100.400002,93.240189,1834100,0.0121743323026205,3.360000999999997,0.0286885661616509,['new indication for novartis bone marrow disorder drug cleared in europe URL premarket $nvs $incy'],"[98.269997, 97.559998]","[100.510002, 97.900002]","[98.120003, 97.050003]","[100.400002, 97.599998]","[93.240189, 90.639862]","[1834100, 1155400]",1.4585202387819909,0.0249323913607972,0.0113808724126863,0.0033710445799566,0.7221716412170285,-0.1020040972046149,0.7964983584078851,0.2503871689022533,0.3764158811992725,0.0760680258841181,0.567117621615971,0.2673351242181386,0.321734163229375,1.0
163,637,637,2015-03-19,99.349998,100.160004,99.349998,99.870003,92.747986,957900,0.0132660268155818,3.360000999999997,-0.0052788743968351,"[""us district court dismisses amgen's petition to block the launch of neupogen biosimilar zarxio URL $nvs $amgn pharma""]","[99.349998, 98.269997]","[100.160004, 100.510002]","[99.349998, 98.120003]","[99.870003, 100.400002]","[92.747986, 93.240189]","[957900, 1834100]",1.411285996560405,0.0281237751732377,0.0116770349185002,0.003261815475523,0.7934020671856502,-0.1296011707088523,0.7476001064573302,0.4985921147338541,0.38706953111636,0.0736010252848805,0.5625098316683774,0.3040007155892314,0.3317952759147123,1.0
164,638,638,2015-03-20,102.0,102.269997,101.239998,101.68,94.428902,2112600,0.0141082705102148,4.080002000000008,0.018123530045353,"['rt AT_USER judge denies amgen ’ s request to block novartis ’ s biosimilar of neupogen $amgn $nvs URL', ""us district court dismisses amgen's petition to block the launch of neupogen biosimilar zarxio URL $nvs $amgn pharma""]","[102.0, 99.349998]","[102.269997, 100.160004]","[101.239998, 99.349998]","[101.68, 99.870003]","[94.428902, 92.747986]","[2112600, 957900]",1.3375221610393786,0.0281237751732377,0.0088881867419669,0.002426081702079,0.1226525979698974,-0.3407519120364823,0.6712376531924805,0.4985921147338541,0.2867482157525461,0.0547255091797136,0.5553140295590676,0.3040007155892314,0.3001971175201397,1.0
165,639,639,2015-03-23,102.309998,102.900002,101.900002,102.360001,95.06041,1588200,0.012531902720493,4.7600029999999975,0.006687657356412,"['“ AT_USER viewpoints : novartis lands first blow in biosimilar legal case URL $nvs $amgn pharma ”', 'rt AT_USER judge denies amgen ’ s request to block novartis ’ s biosimilar of neupogen $amgn $nvs URL']","[102.309998, 102.0]","[102.900002, 102.269997]","[101.900002, 101.239998]","[102.360001, 101.68]","[95.06041, 94.428902]","[1588200, 2112600]",0.9576741144119452,0.0234029835958816,0.0094141704892015,0.0052786271076675,0.2491576269070679,0.3799525708978745,0.2780079830777316,0.1314398426779546,0.3056690669579193,0.1191518473926846,0.518259131914005,0.2497638625198193,0.298210977196107,1.0
166,640,640,2015-03-24,102.860001,103.080002,101.860001,101.889999,94.623932,1469800,0.0095128116749527,2.489998,-0.0045916568523675,"['bristol , sanofi and novartis lead pack in big year for blockbusters . URL by AT_USER $bmy $sny $nvs', '“ AT_USER viewpoints : novartis lands first blow in biosimilar legal case URL $nvs $amgn pharma ”']","[102.860001, 102.309998]","[103.080002, 102.900002]","[101.860001, 101.900002]","[101.889999, 102.360001]","[94.623932, 95.06041]","[1469800, 1588200]",1.2484426801834811,0.0273805595032901,0.0137554939572149,0.0060036818862743,1.2932949293125326,0.5631399193941178,0.5790200014710414,0.4407896641538112,0.4618365071203608,0.1355276163104857,0.5466241571885295,0.2954619613508144,0.3598625604925476,1.0
167,641,641,2015-03-25,102.330002,102.519997,100.309998,100.360001,93.203033,1299100,0.0123606708015363,2.489998,-0.015016174453,"[""in a letter to employees , alcon chief defends company's culture for women URL AT_USER $acl $nvs"", '2015 could be the year of the blockbuster drug URL $gild $gsk $thrx $nvs', 'bristol , sanofi and novartis lead pack in big year for blockbusters . URL by AT_USER $bmy $sny $nvs']","[102.330002, 102.860001]","[102.519997, 103.080002]","[100.309998, 101.860001]","[100.360001, 101.889999]","[93.203033, 94.623932]","[1299100, 1469800]",1.3120073089568236,0.0273805595032901,0.0147233173156879,0.0054443163765029,1.5260673725931575,0.421814480822198,0.6448239412976012,0.4407896641538112,0.4966513504592075,0.1228940324780951,0.5528250073283563,0.2954619613508144,0.3669580879041183,1.0
168,642,642,2015-03-26,99.980003,99.989998,99.050003,99.559998,92.460091,983500,0.0078675134325371,2.800003000000004,-0.0079713331210509,"[""in a letter to employees , alcon chief defends company's culture for women URL AT_USER $acl $nvs"", '2015 could be the year of the blockbuster drug URL $gild $gsk $thrx $nvs']","[99.980003, 102.330002]","[99.989998, 102.519997]","[99.050003, 100.309998]","[99.559998, 100.360001]","[92.460091, 93.203033]","[983500, 1299100]",1.211463158971573,0.0273805595032901,0.0143069677174106,0.0040182432522228,1.4259305941185991,0.061512663488344,0.5407377329263706,0.4407896641538112,0.4816742930123962,0.0906853709643117,0.5430167347320053,0.2954619613508144,0.3527095900148819,1.0
169,645,645,2015-03-31,98.82,99.699997,98.610001,98.610001,91.577835,1764400,0.0147340071971715,2.699996999999996,-0.0266508444704539,"['amgen has lost another round in its battle to fend off a biosimilar rival URL $amgn $nvs', 'rt AT_USER amgen has lost another round in its battle to fend off a biosimilar rival URL $amgn $nvs']","[98.82, 100.379997]","[99.699997, 101.559998]","[98.610001, 100.339996]","[98.610001, 101.309998]","[91.577835, 94.085289]","[1764400, 1121300]",-1.07219112811438,0.0166366307540251,0.0052351801890052,0.0035595272290455,-0.7559367160911256,-0.0543833687536023,-1.8233671504343376,-0.3948027966572985,0.1553411260768012,0.0803250122492389,0.3202419261842151,0.1720256953319552,0.1819834399605526,0.0
170,646,646,2015-04-01,100.029999,100.120003,98.919998,99.860001,92.738693,1405500,0.0161096405124916,2.699996999999996,0.0126761990398924,"['amgen has lost another round in its battle to fend off a biosimilar rival URL $amgn $nvs', 'rt AT_USER amgen has lost another round in its battle to fend off a biosimilar rival URL $amgn $nvs']","[100.029999, 98.82]","[100.120003, 99.699997]","[98.919998, 98.610001]","[99.860001, 98.610001]","[92.738693, 91.577835]","[1405500, 1764400]",-0.5519541128394796,0.0279615256360143,0.0048466468279076,0.0006402207255873,-0.8493833755119261,-0.7919552510380444,-1.284802764716483,0.4859734076260619,0.1413646829788886,0.0143908371890801,0.3709920340848414,0.3021366417010353,0.2072210489884614,1.0
171,648,648,2015-04-06,99.739998,100.540001,99.529999,100.25,93.100883,708100,0.0148611222016088,2.699996999999996,0.004710372867412,"['rt AT_USER $juno to receive $12.25 m , future potential milestones , royalties from $nvs under car-t patent settlement : URL']","[99.739998, 100.309998]","[100.540001, 100.599998]","[99.529999, 99.669998]","[100.25, 99.779999]","[93.100883, 92.664398]","[708100, 1076700]",1.5530424515349548,0.0223055862613501,0.0088606661172289,0.0023797439959974,0.1160335770454791,-0.3524592778286191,0.8943504834072813,0.0460914602893001,0.2857582352664868,0.0536789460932233,0.5763384428097188,0.2371559392475355,0.2882328908542411,1.0
172,649,649,2015-04-07,101.779999,102.379997,101.169998,101.32,94.094574,1144200,0.0052526311506723,2.7099989999999963,0.0106733167082293,"['novartis has finally reached a settlement with juno therapeutics - URL $nvs $juno URL', 'rt AT_USER juno and novartis settle car-t patent fight with little fanfare . URL by AT_USER $juno $nvs', 'rt AT_USER $juno to receive $12.25 m , future potential milestones , royalties from $nvs under car-t patent settlement : URL']","[101.779999, 99.739998]","[102.379997, 100.540001]","[101.169998, 99.529999]","[101.32, 100.25]","[94.094574, 93.100883]","[1144200, 708100]",2.2882596874413608,0.021096214095106,0.0086134586586564,0.0013963046383644,0.0565773925823304,-0.6009282951321187,1.6554686034162562,-0.0479655916524768,0.2768656115588145,0.0314674165089154,0.648060279121066,0.2232615447562725,0.2949137129862671,1.0
173,650,650,2015-04-08,101.910004,102.029999,100.959999,101.440002,94.206024,1307500,0.0043368610412293,1.6600030000000032,0.0011843861034348,"['novartis has finally reached a settlement with juno therapeutics - URL $nvs $juno URL', 'rt AT_USER juno and novartis settle car-t patent fight with little fanfare . URL by AT_USER $juno $nvs']","[101.910004, 101.779999]","[102.029999, 102.379997]","[100.959999, 101.169998]","[101.440002, 101.32]","[94.206024, 94.094574]","[1307500, 1144200]",1.8458512651931365,0.0121165335984573,0.0087141631232315,0.0066052658586695,0.0807979531455701,0.7151319840663475,1.1974746253472073,-0.7463463700996092,0.2804881839290828,0.1491147278050492,0.6049024981366063,0.120094606812411,0.2886500041707874,1.0
174,651,651,2015-04-09,102.599998,102.720001,102.059998,102.57,95.255432,1387200,0.0041469561125953,2.790000999999989,0.0111395699696454,['rt AT_USER novartis ag and juno therapeutics inc reach mutual agreement on a long pending patent dispute $nvs $juno URL'],"[102.599998, 101.910004]","[102.720001, 102.029999]","[102.059998, 100.959999]","[102.57, 101.440002]","[95.255432, 94.206024]","[1387200, 1307500]",1.57854683389118,0.0121165335984573,0.007843682563589,0.0066566402501451,-0.1285624481325763,0.7281118841134954,0.9207533567390368,-0.7463463700996092,0.2491749860731429,0.1502750472566549,0.5788264436987622,0.120094606812411,0.2745927709602427,1.0
175,652,652,2015-04-10,103.32,103.800003,103.120003,103.580002,96.193413,2227800,0.0040590802530656,3.330001999999993,0.0098469533001852,['rt AT_USER novartis ag and juno therapeutics inc reach mutual agreement on a long pending patent dispute $nvs $juno URL'],"[103.32, 102.599998]","[103.800003, 102.720001]","[103.120003, 102.059998]","[103.580002, 102.57]","[96.193413, 95.255432]","[2227800, 1387200]",0.8757693352877752,0.0094782298017677,0.0072956772080964,0.0081941047060936,-0.2603639224534076,1.116557068398201,0.1932177898365677,-0.9515363721269376,0.2294619667155344,0.1849995444847451,0.5102691653101636,0.0897833140919504,0.2536284976505984,1.0
176,655,655,2015-04-15,103.360001,103.519997,102.620003,103.220001,95.859085,1120700,0.0087720030369588,1.240005999999994,-0.0001936943082854,['rt AT_USER $adro here is why $adro jumped + 147 % today : $jnj longtime partner bought $10m shares $adro insiders bought $12.5 m $nvs part …'],"[103.360001, 102.900002]","[103.519997, 103.489998]","[102.620003, 102.75]","[103.220001, 103.239998]","[95.859085, 95.877655]","[1120700, 992400]",0.0634141634531572,0.0178990809448176,0.009249272245589,0.0006513548973917,0.2094977378143661,-0.7891421678466353,-0.6477557496426432,-0.2966176833533846,0.2997372959710339,0.0146423087053568,0.4310223769930085,0.1865298996340251,0.2329829703258561,1.0
177,656,656,2015-04-16,102.989998,103.75,102.809998,103.309998,95.942665,939500,0.0074298191894789,1.240005999999994,0.0008718949731456,"['new sec filing for $nvs filed a moment ago : URL URL', 'rt AT_USER $adro stingvax + anti-pd 1 combo paper published in stm on the same day of its ipo URL $nvs URL', 'rt AT_USER $adro here is why $adro jumped + 147 % today : $jnj longtime partner bought $10m shares $adro insiders bought $12.5 m $nvs part …']","[102.989998, 103.360001]","[103.75, 103.519997]","[102.809998, 102.620003]","[103.309998, 103.220001]","[95.942665, 95.859085]","[939500, 1120700]",0.1905778046718634,0.0318857791839941,0.0120782096898593,0.0004927157046158,0.8898891284807395,-0.8292228540922205,-0.5161122750190443,0.7911761649719251,0.4015007149621405,0.0110593535427188,0.4434274314651047,0.3472221235744165,0.3008024058860952,1.0
178,657,657,2015-04-17,102.610001,102.809998,101.870003,102.459999,95.153282,1244400,0.0060285384550561,0.9700019999999938,-0.0082276547909718,"['new sec filing for $nvs filed a moment ago : URL URL', 'rt AT_USER $adro stingvax + anti-pd 1 combo paper published in stm on the same day of its ipo URL $nvs URL']","[102.610001, 102.989998]","[102.809998, 103.75]","[101.870003, 102.809998]","[102.459999, 103.309998]","[95.153282, 95.942665]","[1244400, 939500]",-1.884127246591112,0.0318857791839941,0.0128199649009117,0.0004385743877432,1.0682896302677811,-0.8429018264604105,-2.6639068737727385,0.7911761649719251,0.4281833644792043,0.0098365415288255,0.2410360173172038,0.3472221235744165,0.2565695117249125,1.0
179,658,658,2015-04-20,102.470001,102.849998,102.099998,102.239998,94.948967,1235500,0.0035351170985114,1.0699999999999932,-0.0021471891679405,"['rt AT_USER $nvs / penn cart-meso solid tumor aacr 15 URL very early data , no response , mkt likely disappointed give …']","[102.470001, 102.610001]","[102.849998, 102.809998]","[102.099998, 101.870003]","[102.239998, 102.459999]","[94.948967, 95.153282]","[1235500, 1244400]",-0.6652452983312817,0.0198163659685751,0.0129572852159703,0.0005934577561,1.101316716221449,-0.8037700609544063,-1.402085072453465,-0.147503802531398,0.433123093629314,0.0133346692900068,0.3599402639895115,0.2085574567548499,0.2537388709159205,1.0
180,659,659,2015-04-21,104.300003,104.660004,103.980003,104.07,96.648468,1542000,0.009637894798425,1.8300019999999928,0.0178990809448176,"['rt AT_USER juno therapeutics gets lift from cancer test results URL ibdnews via AT_USER $juno $kite $nvs $bl …', 'rt AT_USER $nvs / penn cart-meso solid tumor aacr 15 URL very early data , no response , mkt likely disappointed give …']","[104.300003, 102.470001]","[104.660004, 102.849998]","[103.980003, 102.099998]","[104.07, 102.239998]","[96.648468, 94.948967]","[1542000, 1235500]",0.1606705182441593,0.0198163659685751,0.0107190764010605,0.0014300972993624,0.5630022295357874,-0.592390474060515,-0.5470731618273643,-0.147503802531398,0.352609548912172,0.0322306427146432,0.4405099189301327,0.2085574567548499,0.2584768918279495,1.0
181,660,660,2015-04-22,103.379997,103.800003,103.169998,103.449997,96.072678,1424500,0.0102817519122619,1.8300019999999928,-0.0059575574132795,['rt AT_USER juno therapeutics gets lift from cancer test results URL ibdnews via AT_USER $juno $kite $nvs $bl …'],"[103.379997, 104.300003]","[103.800003, 104.660004]","[103.169998, 103.980003]","[103.449997, 104.07]","[96.072678, 96.648468]","[1424500, 1542000]",1.6077331508114263,0.0268639483524225,0.0115417712480319,0.0002515804463838,0.760869627473006,-0.8901464282659619,0.950967875087396,0.4006110299772351,0.3822037842261203,0.0056131784629142,0.5816736242903656,0.2895266510062475,0.3147543094964119,1.0
182,662,662,2015-04-24,104.529999,104.779999,103.949997,104.279999,96.843491,821000,0.0139031816081425,3.260002,-0.0115639905213269,"[""it's earnings season ! $nvs flies , humira sales keep $abbv afloat , $azn feels the sting of patent expirations URL"", 'rt AT_USER twofour today - $agn and $nvs alcon receive cdsco expert comm reviews of proposals india pharma URL']","[104.529999, 105.099998]","[104.779999, 105.82]","[103.949997, 104.110001]","[104.279999, 105.5]","[96.843491, 97.976486]","[821000, 1684500]",1.2094362951722586,0.0211197832675898,0.0094713940535795,0.0093241341711188,0.2629205401255597,1.40206253298994,0.538639464973571,-0.0461325356731763,0.3077275308415083,0.2105218938789754,0.5428190103227556,0.2235323293744927,0.321150191104433,1.0
183,663,663,2015-04-27,104.989998,105.5,103.860001,103.910004,96.499878,1424000,0.0119172298736907,2.050003000000004,-0.0035480917102809,"['dodge & cox global stock fund q1 letter URL $nsany $ntdoy $msft $emc $nvs URL', ""rt AT_USER $cldn yet another data point against the big pharma / corporate ' validation ' axiom . $pfe , $jnj , $nvs were all corp investo …"", ""it's earnings season ! $nvs flies , humira sales keep $abbv afloat , $azn feels the sting of patent expirations URL"", 'rt AT_USER twofour today - $agn and $nvs alcon receive cdsco expert comm reviews of proposals india pharma URL']","[104.989998, 104.529999]","[105.5, 104.779999]","[103.860001, 103.949997]","[103.910004, 104.279999]","[96.499878, 96.843491]","[1424000, 821000]",1.2466469159350708,0.0211197832675898,0.0095508083173609,0.0034065714799055,0.282020567057018,-0.0930281152595876,0.577160974448852,-0.0461325356731763,0.3105842454766888,0.0768704208494294,0.5464489769789423,0.2235323293744927,0.2893589931698883,1.0
184,664,664,2015-04-28,103.410004,104.5,102.900002,103.949997,96.537018,1175000,0.0114815533256633,2.050003000000004,0.0003848811323305,"['dodge & cox global stock fund q1 letter URL $nsany $ntdoy $msft $emc $nvs URL', ""rt AT_USER $cldn yet another data point against the big pharma / corporate ' validation ' axiom . $pfe , $jnj , $nvs were all corp investo …""]","[103.410004, 104.989998]","[104.5, 105.5]","[102.900002, 103.860001]","[103.949997, 103.910004]","[96.537018, 96.499878]","[1175000, 1424000]",1.2181072901628622,0.0177799405369368,0.0108911739042873,0.0006599027486512,0.6043936218367565,-0.7869825265977672,0.547615929457186,-0.305883644523312,0.3588002939085533,0.0148353667212467,0.5436648823358157,0.1851611035982383,0.2756154116409635,1.0
185,667,667,2015-05-01,102.089996,103.5,102.089996,103.349998,95.979805,1005100,0.0105209752111757,2.1499939999999924,0.0152258836377441,"[""rt AT_USER multiple sclerosis drug prices rose at an ' alarming ' rate , a new study finds URL pharma $biib $teva $nvs …""]","[102.089996, 102.43]","[103.5, 103.18]","[102.089996, 101.639999]","[103.349998, 101.800003]","[95.979805, 94.540352]","[1005100, 1301900]",1.0393236497075462,0.0200846805159004,0.0089586432583794,0.000671725959647,0.1395981855368837,-0.7839953555081649,0.3625339405346178,-0.1266360531165201,0.2892826995089335,0.0151024005742001,0.526224198998088,0.2116401043238447,0.2605623508512666,1.0
186,668,668,2015-05-04,103.269997,103.739998,103.120003,103.610001,96.221268,1306200,0.0106483102045291,2.1499939999999924,0.0025157523467005,"['novartis ag $nvs trading near $101.57 support level ( URL )', ""rt AT_USER multiple sclerosis drug prices rose at an ' alarming ' rate , a new study finds URL pharma $biib $teva $nvs …""]","[103.269997, 102.089996]","[103.739998, 103.5]","[103.120003, 102.089996]","[103.610001, 103.349998]","[96.221268, 95.979805]","[1306200, 1005100]",1.0058586111332504,0.0132913064881363,0.0088992526855608,0.0011856185293652,0.125314082325495,-0.6541587968973986,0.3278899659353357,-0.6549802234422974,0.2871462833226718,0.0267089525459704,0.5229596209909914,0.1335914925705264,0.24260158735754,1.0
187,669,669,2015-05-05,104.209999,104.269997,102.029999,102.169998,94.883957,1303500,0.0112614929598317,1.809997999999993,-0.0138983011881255,['novartis ag $nvs trading near $101.57 support level ( URL )'],"[104.209999, 103.269997]","[104.269997, 103.739998]","[102.029999, 103.120003]","[102.169998, 103.610001]","[94.883957, 96.221268]","[1303500, 1306200]",0.9101294589688562,0.0132913064881363,0.0067448578717166,0.0004749128474944,-0.3928421909440884,-0.8337208014031717,0.2287883823937169,-0.6549802234422974,0.2096477219608649,0.0106572660275425,0.5136210605676979,0.1335914925705264,0.2168793852816579,1.0
188,672,672,2015-05-08,102.690002,103.5,102.68,102.919998,95.580475,899500,0.0098423938881692,2.040001000000004,0.0132913064881363,"[""lawsuits continue to delay $nvs's zarxio . URL $amgn doubles down on delay tactics ."", ""rt AT_USER european commission approves novartis ' lung cancer drug zykadia URL $nvs pharma"", 'potential novartis ag $nvs trade targets 2.49 % return ( URL )']","[102.690002, 101.779999]","[103.5, 102.129997]","[102.68, 101.43]","[102.919998, 101.57]","[95.580475, 94.326752]","[899500, 1117600]",0.9860605932451773,0.0146484372138977,0.0057098937525957,0.0015929311939145,-0.6417627450993977,-0.5512499833438922,0.3073944859343847,-0.5494314777975617,0.1724176702648902,0.0359083375700506,0.5210282867826646,0.149183475093578,0.2196344424277958,1.0
189,673,673,2015-05-11,101.910004,103.0,101.889999,102.419998,95.116135,970900,0.0074999046735462,1.3499980000000136,-0.0048581423408111,"[""lawsuits continue to delay $nvs's zarxio . URL $amgn doubles down on delay tactics ."", ""rt AT_USER european commission approves novartis ' lung cancer drug zykadia URL $nvs pharma"", 'potential novartis ag $nvs trade targets 2.49 % return ( URL )']","[101.910004, 102.690002]","[103.0, 103.5]","[101.889999, 102.68]","[102.419998, 102.919998]","[95.116135, 95.580475]","[970900, 899500]",0.9227484564535724,0.0162108981208808,0.0047020242796538,0.0014323054299784,-0.8841667309825165,-0.5918325829816428,0.2418519331007733,-0.4279134945108164,0.1361622756215534,0.0322805145833279,0.5148520677147166,0.1671344820910535,0.2126073350026628,1.0
190,674,674,2015-05-12,102.230003,102.760002,101.940002,102.400002,95.097565,1130300,0.0067860071484156,1.3499980000000136,-0.0001952353094168,['physician views : which companies excel in diabetes drug marketing and why ? URL $azn $jnj $lly $nvo $nvs $sny'],"[102.230003, 101.910004]","[102.760002, 103.0]","[101.940002, 101.889999]","[102.400002, 102.419998]","[95.097565, 95.116135]","[1130300, 970900]",1.126924694918299,0.0135385217403041,0.0051068202604379,0.0004071591655701,-0.7868087279415922,-0.8508389802067367,0.4532210729702848,-0.635753439113235,0.1507237227408175,0.0091270111126594,0.5347698471663641,0.1364317317737687,0.2077630781984024,1.0
191,675,675,2015-05-13,102.870003,103.309998,102.559998,102.669998,95.348305,943800,0.0066336299484641,1.3499980000000136,0.0026366796360024,['physician views : which companies excel in diabetes drug marketing and why ? URL $azn $jnj $lly $nvo $nvs $sny'],"[102.870003, 102.230003]","[103.309998, 102.760002]","[102.559998, 101.940002]","[102.669998, 102.400002]","[95.348305, 95.097565]","[943800, 1130300]",1.2869538820142383,0.0054106086956521,0.0055838070245848,0.0005118847148022,-0.6720880265543354,-0.8243797439535749,0.618887910036291,-1.267889319826713,0.1678820392074489,0.0114922963912558,0.550380997995524,0.0430506921027399,0.1932015064242422,0.0
192,676,676,2015-05-14,104.160004,104.209999,103.480003,103.900002,96.490593,973300,0.0061249325053911,1.5,0.0119801697083894,['rt AT_USER asco 15 $clvs $azn egfrm t790m late-comer competition 1 -> $nvs egf 816 : 54.5 % orr URL'],"[104.160004, 102.870003]","[104.209999, 103.309998]","[103.480003, 102.559998]","[103.900002, 102.669998]","[96.490593, 95.348305]","[973300, 943800]",2.698034408311534,0.0124637777777778,0.0057635965893068,0.0016203762522263,-0.6288466066295987,-0.5443159038649266,2.0796792311654846,-0.719339990490046,0.1743494854360992,0.0365281996082171,0.6880345806192425,0.1240840715503485,0.2557490843034768,1.0
193,677,677,2015-05-15,103.260002,103.949997,102.970001,103.75,96.351288,1151600,0.0052265291420288,1.5,-0.0014437150828928,['rt AT_USER asco 15 $clvs $azn egfrm t790m late-comer competition 1 -> $nvs egf 816 : 54.5 % orr URL'],"[103.260002, 104.160004]","[103.949997, 104.209999]","[102.970001, 103.480003]","[103.75, 103.900002]","[96.351288, 96.490593]","[1151600, 973300]",3.032185373403744,0.0124637777777778,0.0071985794013402,0.0009881612177856,-0.2837170410963497,-0.7040470017844387,2.425601962474444,-0.719339990490046,0.2259691341638421,0.0222492683938695,0.7206316412581651,0.1240840715503485,0.2732335288415563,1.0
194,687,687,2015-06-01,103.830002,103.919998,102.779999,103.279999,95.914803,976100,0.011418831417119,2.440002000000007,0.0053538010701703,"['rt AT_USER can the nosebleed-high prices of cancer drugs ever be contained ? URL asco 15 $bmy $mrk $nvs', 'correction :p i study of medi 4736 wdabrafenib + / - trametinib in adv melanoma 69 % orr w / triple therapy $azn $nvs asco 15 URL']","[103.830002, 104.089996]","[103.919998, 104.559998]","[102.779999, 102.260002]","[103.279999, 102.730003]","[95.914803, 95.40403]","[976100, 2149100]",0.5325735070629041,0.0221805989317705,0.0074393508252549,0.0017367997637486,-0.2258087956235336,-0.5149011409978056,-0.1620684450561758,0.0363707638168135,0.2346302388279068,0.0391576899274887,0.4767897611115725,0.2357199683263742,0.2465744145483355,1.0
195,688,688,2015-06-02,103.089996,103.370003,102.739998,102.940002,95.599045,833000,0.0085874302682964,1.5199970000000036,-0.0032919926732376,"['rt AT_USER can the nosebleed-high prices of cancer drugs ever be contained ? URL asco 15 $bmy $mrk $nvs', 'correction :p i study of medi 4736 wdabrafenib + / - trametinib in adv melanoma 69 % orr w / triple therapy $azn $nvs asco 15 URL']","[103.089996, 103.830002]","[103.370003, 103.919998]","[102.739998, 102.779999]","[102.940002, 103.279999]","[95.599045, 95.914803]","[833000, 976100]",0.2747039121511339,0.0313308232411893,0.0077282460750925,0.0013742903828414,-0.1563262267558379,-0.6064902653685276,-0.4290224984996506,0.7480153238390446,0.245022468749183,0.0309702121983187,0.4516340928645759,0.3408462725255638,0.2671182615844104,1.0
196,693,693,2015-06-09,100.510002,100.860001,100.199997,100.540001,93.370201,1011000,0.0055148723654135,3.150001000000003,-0.0088722494307522,['nvs novartis a g stock forum URL $nvs $gdx $ecig $brwc nvs stock pennystocks'],"[100.510002, 101.309998]","[100.860001, 101.699997]","[100.199997, 100.989998]","[100.540001, 101.440002]","[93.370201, 94.206024]","[1011000, 964100]",1.869772995595387,0.0264708917543613,0.0134915611040139,0.0040669435931278,1.2298160986315338,0.0738169563286621,1.22223909165991,0.3700416602730224,0.4523422323069637,0.091785295483685,0.6072361083247287,0.2850108505080295,0.3590936216558518,1.0
197,694,694,2015-06-10,102.099998,102.889999,101.660004,102.629997,95.31115,1237800,0.0136051206743661,2.510002,0.0207877061787575,"[""rt AT_USER pegph 20 only clinical way to remove ha that binds t's in car-t / tcr etc undervalued gateway drug for $kite $juno $nvs $cll …"", 'nvs novartis a g stock forum URL $nvs $gdx $ecig $brwc nvs stock pennystocks']","[102.099998, 100.510002]","[102.889999, 100.860001]","[101.660004, 100.199997]","[102.629997, 100.540001]","[95.31115, 93.370201]","[1237800, 1011000]",1.8203123416782885,0.0264708917543613,0.0094402548006917,0.0009426130468232,0.2554311982811322,-0.7155548890691601,1.1710359940102937,0.3700416602730224,0.3066073799364011,0.0212205374009616,0.6024111276920033,0.2850108505080295,0.3038124738843489,1.0
198,695,695,2015-06-11,102.800003,102.980003,102.010002,102.760002,95.431885,819500,0.0107686224630729,2.2200009999999963,0.0012667349098722,"[""rt AT_USER pegph 20 only clinical way to remove ha that binds t's in car-t / tcr etc undervalued gateway drug for $kite $juno $nvs $cll …""]","[102.800003, 102.099998]","[102.980003, 102.889999]","[102.010002, 101.660004]","[102.760002, 102.629997]","[95.431885, 95.31115]","[819500, 1237800]",1.3203417432479994,0.0170812005086284,0.0098177005860026,0.0022698176247567,0.3462111705597648,-0.3802325179637869,0.6534519884233158,-0.3602270707826664,0.3201849773042099,0.0511961973319931,0.5536380472066209,0.1771333269789824,0.2755381372054516,1.0
199,696,696,2015-06-12,102.099998,102.209999,101.510002,101.82,94.558922,749400,0.0120964015535987,2.2200009999999963,-0.0091475475058866,"[""novartis ' arzerra extends progression-free survival by 54 % in blood cancer URL premarket $nvs""]","[102.099998, 102.800003]","[102.209999, 102.980003]","[101.510002, 102.010002]","[101.82, 102.760002]","[94.558922, 95.431885]","[749400, 819500]",1.620044362704637,0.0144840374140041,0.0105498627325056,0.0006300114265573,0.5223044320284534,-0.7945346622418497,0.9637127972594676,-0.5622174182627147,0.3465225421149551,0.0141602544432505,0.5828746063689626,0.1472946969839408,0.2727130249777773,1.0
200,697,697,2015-06-15,99.220001,100.279999,99.040001,100.110001,92.970863,1439900,0.0140679937534386,2.650001000000003,-0.0167943331369082,"[""novartis ' arzerra extends progression-free survival by 54 % in blood cancer URL premarket $nvs""]","[99.220001, 102.099998]","[100.279999, 102.209999]","[99.040001, 101.510002]","[100.110001, 101.82]","[92.970863, 94.558922]","[1439900, 749400]",1.6655409222068729,0.0192634091373707,0.0110802005059486,0.0033481766300902,0.6498566534204915,-0.1077817559763014,1.0108121498644524,-0.1905091658478671,0.365600017707425,0.0755515404078681,0.5873128820703285,0.2022045733630867,0.3076672533871771,1.0
201,707,707,2015-06-29,99.730003,99.940002,98.440002,98.529999,91.503532,1665000,0.0023159439770262,4.25,-0.0139111191735612,['$nvs gobbles up spinifex : URL $200m for pain pill co'],"[99.730003, 100.5]","[99.940002, 100.830002]","[98.440002, 99.660004]","[98.529999, 99.919998]","[91.503532, 92.794411]","[1665000, 1511300]",0.8398806125200233,0.014846522873562,0.0082211001516275,0.0034552719302901,-0.0377892576162686,-0.0807237947589075,0.1560647473499632,-0.5340256716280442,0.2627515691198853,0.0779703478414609,0.5067681523114699,0.1514592677529919,0.249737334256452,1.0
202,708,708,2015-06-30,99.470001,99.470001,97.849998,98.339996,91.32708,5584400,0.0042917459077571,3.290001000000004,-0.0019283771635885,['$nvs gobbles up spinifex : URL $200m for pain pill co'],"[99.470001, 99.730003]","[99.470001, 99.940002]","[97.849998, 98.440002]","[98.339996, 98.529999]","[91.32708, 91.503532]","[5584400, 1665000]",0.3365094821679816,0.0129923471272537,0.0081826581940542,0.0064547987886795,-0.0470349823763586,0.6771160101003105,-0.3650395871097785,-0.6782313258902263,0.2613687230469566,0.1457163446199477,0.457663343485194,0.1301567688246846,0.2487262949941957,1.0
203,709,709,2015-07-01,98.400002,99.279999,98.220001,98.519997,91.494255,6571500,0.0061355950840844,2.480003999999994,0.0018303946239737,['$nvs novartis ag ( adr ) ( nvs ) looks at performance based pricing system ahead of ... URL'],"[98.400002, 99.470001]","[99.279999, 99.470001]","[98.220001, 97.849998]","[98.519997, 98.339996]","[91.494255, 91.32708]","[6571500, 5584400]",0.5274418480678302,0.0141958421964356,0.008883991952615,0.0047383509577126,0.121643703776612,0.2434501185505192,-0.1673808866803748,-0.5846313560932805,0.2865973194832555,0.1069494074605444,0.4762891580401597,0.1439836417478772,0.2534548816829592,1.0
204,710,710,2015-07-02,99.830002,99.970001,99.360001,99.800003,92.682976,3750900,0.0096123477201762,1.5800020000000077,0.0129923471272537,['$nvs novartis ag ( adr ) ( nvs ) looks at performance based pricing system ahead of ... URL'],"[99.830002, 98.400002]","[99.970001, 99.279999]","[99.360001, 98.220001]","[99.800003, 98.519997]","[92.682976, 91.494255]","[3750900, 6571500]",1.0673247984154777,0.0466436611242041,0.0145649328417494,0.0006229634161016,1.4879741186397195,-0.796315364039353,0.3915215385149589,1.938947634288819,0.4909538948241477,0.0140010711732987,0.5289557641819267,0.5167744245584771,0.3876712886844625,1.0
205,714,714,2015-07-09,101.010002,101.360001,99.989998,100.019997,92.887283,1661000,0.008248206776568,1.3999940000000066,0.0099969505200137,"['rt AT_USER after entresto , maybe innovation ? URL $nvs $cyad $amgn $agn $trvn $mrk']","[101.010002, 99.419998]","[101.360001, 99.769997]","[99.989998, 98.75]","[100.019997, 99.029999]","[92.887283, 91.96788]","[1661000, 1661700]",2.636355998037597,0.0261576920542755,0.015577008186394,0.0042899832223908,1.731389664146598,0.1301686134721171,2.0158279592145947,0.3456830374426264,0.5273605843945505,0.0968227706318954,0.682017734672809,0.281412520474478,0.3969034025434332,1.0
206,715,715,2015-07-10,103.870003,103.949997,102.989998,103.220001,95.859085,2479300,0.0122889536343423,4.599997999999999,0.0319936422313629,"['rt AT_USER after entresto , maybe innovation ? URL $nvs $cyad $amgn $agn $trvn $mrk']","[103.870003, 101.010002]","[103.949997, 101.360001]","[102.989998, 99.989998]","[103.220001, 100.019997]","[95.859085, 92.887283]","[2479300, 1661000]",1.952666357800212,0.0173854287063162,0.0119921438690555,0.0068451759165369,0.869189326997273,0.7757460075512446,1.3080526946622626,-0.336566192691729,0.3984047284457156,0.1545332310473034,0.615322513083755,0.1806285840322087,0.3372222641522457,1.0
207,716,716,2015-07-13,104.580002,104.650002,103.75,104.110001,96.685608,2326200,0.0119962252694951,5.080001999999993,0.0086223599242165,"['watch : latest pharma daily news round-up video - fda , $nvo , semaglutide , $abbv , imbruvica , $nvs , entresto URL']","[104.580002, 103.870003]","[104.650002, 103.949997]","[103.75, 102.989998]","[104.110001, 103.220001]","[96.685608, 95.859085]","[2326200, 2479300]",3.199998051714005,0.0178400245954339,0.0118676407391664,0.0086751318633036,0.8392449187675567,1.2380900781568642,2.5993264944785275,-0.3012106996940247,0.3939260630732203,0.1958638126780999,0.7370020864231224,0.1858514052561536,0.378160841857649,1.0
208,717,717,2015-07-14,105.150002,105.989998,104.940002,105.919998,98.366539,1832900,0.0090898009772754,6.889999000000003,0.0173854287063162,"['watch : latest pharma daily news round-up video - fda , $nvo , semaglutide , $abbv , imbruvica , $nvs , entresto URL']","[105.150002, 104.580002]","[105.989998, 104.650002]","[104.940002, 103.75]","[105.919998, 104.110001]","[98.366539, 96.685608]","[1832900, 2326200]",3.1345681887618384,0.0232379136364662,0.0134840379053395,0.0111188180831114,1.2280066844224278,1.8554950141308983,2.531591610351114,0.1186017815912838,0.4520716054606872,0.2510558368174084,0.7306192791501893,0.2478673849930566,0.4204035266053353,2.0
209,722,722,2015-07-21,106.730003,106.730003,102.879997,103.709999,96.31414,3123600,0.0136918015641953,2.4100040000000007,-0.0227101765159203,"['nvs novartis a g last price URL $nvs $xli $amd $nclh nvs investing finance', 'novartis ( nvs ) beats on earnings & revenues in q2 $nvs URL', 'rt AT_USER novartis q2 revenues off 5 % ; net income off 29 % ; cash flow ops off 13 % URL premarket $nvs', 'federal circuit $amgn $nvs sandoz zarxio ruling URL biosimialrs pharna biotech']","[106.730003, 106.730003]","[106.730003, 106.839996]","[102.879997, 105.690002]","[103.709999, 106.120003]","[96.31414, 98.552277]","[3123600, 2228000]",0.7558959327189132,0.0172754190342916,0.0150316093903215,0.0065901977321332,1.600215096791238,0.7113249749569192,0.0691213808482643,-0.3451220249859767,0.5077413290043743,0.1487744057142732,0.4985752874503379,0.1793646903991088,0.3336139281420235,1.0
210,723,723,2015-07-22,102.709999,102.790001,101.0,101.300003,94.076004,3047900,0.012376408167498,4.819999999999993,-0.0232378364982916,"['nvs novartis a g last price URL $nvs $xli $amd $nclh nvs investing finance', 'novartis ( nvs ) beats on earnings & revenues in q2 $nvs URL', 'rt AT_USER novartis q2 revenues off 5 % ; net income off 29 % ; cash flow ops off 13 % URL premarket $nvs', 'federal circuit $amgn $nvs sandoz zarxio ruling URL biosimialrs pharna biotech']","[102.709999, 106.730003]","[102.790001, 106.730003]","[101.0, 102.879997]","[101.300003, 103.709999]","[94.076004, 96.31414]","[3047900, 3123600]",0.7113549682583924,0.021173931247056,0.0106618462237119,0.0070434489650041,0.5492377258232138,0.8258403109041096,0.0230112878336688,-0.0419212602202181,0.3505508471447445,0.1590113390746248,0.4942302318583691,0.2241544318245141,0.3069867124755631,1.0
211,724,724,2015-07-23,103.610001,103.610001,102.669998,103.050003,95.70121,2608400,0.0173767863864133,4.819999999999993,0.0172754190342916,['$bmy and $exel make headway against $nvs in kidney cancer URL'],"[103.610001, 102.709999]","[103.610001, 102.790001]","[102.669998, 101.0]","[103.050003, 101.300003]","[95.70121, 94.076004]","[2608400, 3047900]",1.0204035908243156,0.021173931247056,0.0090070365142631,0.0053505824586086,0.1512373098788777,0.3981323144675187,0.3429473490561003,-0.0419212602202181,0.2910235167846252,0.1207769993593745,0.5243785113564604,0.2241544318245141,0.2900833648312436,1.0
212,725,725,2015-07-24,103.300003,103.410004,101.580002,101.800003,94.540352,1301200,0.0165153152590073,4.819999999999993,-0.0121300336109645,['$bmy and $exel make headway against $nvs in kidney cancer URL'],"[103.300003, 103.610001]","[103.410004, 103.610001]","[101.580002, 102.669998]","[101.800003, 103.050003]","[94.540352, 95.70121]","[1301200, 2608400]",0.7969868656649695,0.0217648116824422,0.0065778961245748,0.0067602450034311,-0.432998375930073,0.7542879477793859,0.1116599015818812,0.0040335528255468,0.2036417219822189,0.1526150187300618,0.5025837859222274,0.2309430169231131,0.2724458858894054,1.0
